Поиск
Закладки
Озвучить текст Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.
Трансплантация легкого (легких), трансплантация легочно - сердечного комплекса, наличие трансплантированного легкого, наличие трансплантированного легочно - сердечного комплекса , отмирание и отторжение трансплантата легкого, отмирание и отторжение легочно - сердечного трансплантата

Список литературы

  1. Демихов В. П. Пересадка жизненно важных органов в эксперименте. – 1960. – Москва: Медгиз, 1960. – 259 с.
  2. Hardy J. D. et al. Lung homotransplantation in man: report of the initial case //Jama. – 1963. – Т. 186. – №. 12. – С. 1065-1074.
  3. Cooley D.A. et al. Organ Transplantetion for advanced cardiopulmonary disease. Ann Thorac Surg 1964;8:30-46.
  4. Nelems J. et al. Human lung transplantation. Chest. – 1980. – Vol. 186. – № 12. – P. 569-573.
  5. Яблонский, П. К. Трансплантация изолированного легкого (Экспериментальное и клиническое исследование): специальность 14.00.27 «Хирургия»:автореферат диссертации на соискание ученой степени доктора медицинских наук / Яблонский Петр Казимирович ; Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова. – Санкт- Петербург, 1999. – 32 с. - Библиогр.: с. 32-34. - Текст: непосредственный.
  6. Первая в России успешная двусторонняя трансплантация легких / П.К. Яблонский, А.Г Чучалин, Ж. Массард и др. - Текст: непосредственный // Вестник хирургии. - 2007. — Т. 166. — № 1. — С. 88–95. – Библиогр.: с. 95 (назв.7).
  7. Первая трансплантация легких в НИИ скорой помощи им. Н.В. Склифосовского / М.Ш. Хубутия, А. Г. Чучалин, М.М. Абакумов и др.-Текст: непосредственный // Трансплантология. - 2011. — № 2-3. — С. 5–9. – Библиогр.: с. 9 (назв. 7).
  8. Готье С. В. Трансплантология: итоги и перспективы. Том VI. 2014 год / С.В. Готье. - Текст: непосредственный // Тверь: Триада. – 2015. – С. 448.
  9. Yusen R. D. et al. The registry of the international society for heart and lung transplantation: thirty-third adult lung and heart–lung transplant report—2016; focus theme: primary diagnostic indications for transplant //The Journal of Heart and Lung Transplantation. – 2016. – Т. 35. – №. 10. – С. 1170-1184.
  10. Weill, David, et al. "A consensus document for the selection of lung transplant candidates: 2014—an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation." The Journal of Heart and Lung Transplantation 34.1 (2015): 1-15.
  11. Chambers D. C. et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult lung and heart–lung transplantation Report—2019; Focus theme: Donor and recipient size match //The Journal of Heart and Lung Transplantation. – 2019. – Т. 38. – №. 10. – С. 1042-1055.
  12. Сведения о смертности населения по причинам смерти по Российской Федерации за январь - декабрь 2018 года / Федеральная служба государственной статистики - Текст: электронный // Официальная статистика. - 2019. - URL: http://webcache.googleusercontent.com/search?q=cache:YcYhzF1iCykJ:www.gks.ru/fr ee_doc/2018/demo/t3_3.xls+&cd=1&hl=ru&ct=clnk&gl=ru
  13. Готье С.В. Оценка потребности населения в трансплантации органов, донорского ресурса и планирование эффективной сети медицинских организаций (центров трансплантации) / С.В. Готье, С.М. Хомяков. - Текст: непосредственный // Вестник трансплантологии и искусственных органов. - 2018. - Т. 15. - № 3. С. 11-24. - Библиогр.: с. 24 (назв.4)
  14. О порядке установления диагноза смерти мозга человека: Приказ Министерства здравоохранения РФ от 25 декабря 2014 г. № 908н : сайт / Справочная правовая система «ГАРАНТ.РУ». - 2014. - URL: http:// http://www.garant.ru/products/ipo/prime/doc/70921232 (дата обращения: ) - Текст: электронный.
  15. Martens A. et al. A retrospective database analysis to evaluate the potential of ex vivo lung perfusion to recruit declined lung donors //Transplant International. – 2017. – Т. 30. – №. 10. – С. 1002-1010.
  16. Thabut G. et al. Survival after bilateral versus single lung transplantation for patients with chronic obstructive pulmonary disease: a retrospective analysis of registry data //The Lancet. – 2008. – Т. 371. – №. 9614. – С. 744-751.
  17. Crawford T. C. et al. Five-year mortality hazard is reduced in chronic obstructive pulmonary disease patients receiving double-versus single-lung transplants //Journal of Surgical Research. – 2019. – Т. 237. – С. 118-125.
  18. Antończyk R. et al. Single Lung Transplant vs Double Lung Transplant: A Single-Center Experience With Particular Consideration for Idiopathic Pulmonary Arterial Hypertension //Transplantation Proceedings. – Elsevier, 2020.
  19. Pierson III R. N. et al. Successful management of an ABO-mismatched lung allograft using antigen-specific immunoadsorption, complement inhibition, and immunomodulatory therapy1 //Transplantation. – 2002. – Т. 74. – №. 1. – С. 79-84.
  20. Snell G. I. et al. Lessons and insights from ABO‐incompatible lung transplantation //American Journal of Transplantation. – 2013. – Т. 13. – №. 5. – С. 1350-1353.
  21. Novick R. J. et al. Pulmonary Retransplantation: Predictors of Graft Function and Survival in 230 Patients-reporting on studies using secondary data sources //The Annals of Thoracic Surgery. – 1998. – Т. 65. – №. 1. – С. 227-234.
  22. Aigner C. et al. Pulmonary retransplantation: is it worth the effort? A long-term analysis of 46 cases //The Journal of heart and lung transplantation. – 2008. – Т. 27. – №. 1. – С. 60-65.
  23. Holcomb Jr B. W. et al. Pulmonary veno-occlusive disease: a case series and new observations //Chest. – 2000. – Т. 118. – №. 6. – С. 1671-1679.
  24. Kadikar A., Maurer J., Kesten S. The six-minute walk test: a guide to assessment for lung transplantation //The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation. – 1997. – Т. 16. – №. 3. – С. 313-319.
  25. Santambrogio L. et al. Transplant options for end stage chronic obstructive pulmonary disease in the context of multidisciplinary treatments //Journal of Thoracic Disease. – 2018. – Т. 10. – №. Suppl 27. – С. S3356.
  26. Lane C. R., Tonelli A. R. Lung transplantation in chronic obstructive pulmonary disease: patient selection and special considerations //International journal of chronic obstructive pulmonary disease. – 2015. – Т. 10. – С. 2137.
  27. Aziz F. et al. Lung transplant in end-staged chronic obstructive pulmonary disease (COPD) patients: a concise review //Journal of thoracic disease. – 2010. – Т. 2. – №. 2. – С. 111.
  28. Siddiqui F. M., Diamond J. M. Lung transplantation for chronic obstructive pulmonary disease: past, present, and future directions //Current opinion in pulmonary medicine. – 2018. – Т. 24. – №. 2. – С. 199.
  29. Raghu G. et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management //American journal of respiratory and critical care medicine. – 2011. – Т. 183. – №. 6. – С. 788-824.
  30. Laporta Hernandez R. et al. Lung transplantation in idiopathic pulmonary fibrosis //Medical Sciences. – 2018. – Т. 6. – №. 3. – С. 68.
  31. Fisher J. H. et al. Multi-dimensional scores to predict mortality in patients with idiopathic pulmonary fibrosis undergoing lung transplantation assessment //Respiratory Medicine. – 2017. – Т. 125. – С. 65-71.
  32. De Oliveira N. C. et al. Lung transplant for interstitial lung disease: outcomes for single versus bilateral lung transplantation //Interactive cardiovascular and thoracic surgery. – 2012. – Т. 14. – №. 3. – С. 263-267.
  33. Park J. E. et al. Comparison of short-term outcomes for connective tissue disease-related interstitial lung disease and idiopathic pulmonary fibrosis after lung transplantation //Journal of Thoracic Disease. – 2018. – Т. 10. – №. 3. – С. 1538.
  34. Kubo M. et al. Lung transplantation in patients with scleroderma //The Journal of Heart and Lung Transplantation. – 2001. – Т. 20. – №. 2. – С. 174-175.
  35. Saggar R. et al. Systemic sclerosis and bilateral lung transplantation: a single centre experience //European Respiratory Journal. – 2010. – Т. 36. – №. 4. – С. 893-900.
  36. Schachna L. et al. Lung transplantation in scleroderma compared with idiopathic pulmonary fibrosis and idiopathic pulmonary arterial hypertension //Arthritis & Rheumatism: Official Journal of the American College of Rheumatology. – 2006. – Т. 54. – №. 12. – С. 3954-3961.
  37. Shitrit D. et al. Lung transplantation in patients with scleroderma: case series, review of the literature, and criteria for transplantation //Clinical transplantation. – 2009. – Т. 23. – №. 2. – С. 178-183.
  38. Savi D. et al. Survival after lung transplant for cystic fibrosis in Italy: a single center experience with 20 years of follow-up //Transplantation Proceedings. – Elsevier, 2018. – Т. 50. – №. 10. – С. 3732-3738.
  39. Lynch III J. P. et al. Lung transplantation for cystic fibrosis: results, indications, complications, and controversies //Seminars in respiratory and critical care medicine. – NIH Public Access, 2015. – Т. 36. – №. 2. – С. 299.
  40. Snell G. et al. The evolution of lung transplantation for cystic fibrosis: a 2017 update //Journal of Cystic Fibrosis. – 2017. – Т. 16. – №. 5. – С. 553-564.
  41. Rosenbluth D. B. et al. Lung function decline in cystic fibrosis patients and timing for lung transplantation referral //Chest. – 2004. – Т. 126. – №. 2. – С. 412-419.
  42. Mayer-Hamblett N. et al. Developing cystic fibrosis lung transplant referral criteria using predictors of 2-year mortality //American journal of respiratory and critical care medicine. – 2002. – Т. 166. – №. 12. – С. 1550-1555.
  43. Augarten A. et al. Prediction of mortality and timing of referral for lung transplantation in cystic fibrosis patients //Pediatric transplantation. – 2001. – Т. 5. – №. 5. – С. 339-342.
  44. Galiè N. et al. Рекомендации ESC/ERS по диагностике и лечению легочной гипертензии 2015 //Российский кардиологический журнал. – 2016. – №. 5. – С. 5-64.
  45. Mendeloff E. N. et al. Lung transplantation for pulmonary vascular disease //The Annals of thoracic surgery. – 2002. – Т. 73. – №. 1. – С. 209-219.
  46. George M. P., Champion H. C., Pilewski J. M. Lung transplantation for pulmonary hypertension //Pulmonary circulation. – 2011. – Т. 1. – №. 2. – С. 182-191.
  47. Pirard L., Marchand E. Reassessing the BODE score as a criterion for listing COPD patients for lung transplantation //International journal of chronic obstructive pulmonary disease. – 2018. – Т. 13. – С. 3963.
  48. Quezada-Loaiza C. A. et al. Lung transplantation in pulmonary hypertension: a multidisciplinary unit"s management experience //Transplantation Proceedings. – Elsevier, 2018. – Т. 50. – №. 5. – С. 1496-1503.
  49. Taghavi, Sharven, et al. "Single-lung transplantation with ABO-compatible donors results in excellent outcomes." The Journal of Heart and Lung Transplantation 33.8 (2014): 822-828.
  50. Taghavi, Sharven, et al. "Examining ABO compatible donors in double lung transplants during the era of lung allocation score." The Annals of Thoracic Surgery 98.4 (2014): 1167-1174.
  51. YU, Song-Hyeon, et al. "Lung transplantation in ABO compatible but nonidentical patients." The Korean Journal of Thoracic and Cardiovascular Surgery (2001): 94-96.
  52. Kim, Hyoung Soo, and Sunghoon Park. "Recipient Management before Lung Transplantation." Journal of Chest Surgery 55.4 (2022): 265.
  53. Opelz, Gerhard, et al. "Impact of HLA compatibility on lung transplant survival and evidence for an HLA restriction phenomenon: a collaborative transplant study report." Transplantation 90.8 (2010): 912-917.
  54. Peltz, Matthias, et al. "HLA mismatches influence lung transplant recipient survival, bronchiolitis obliterans and rejection: implications for donor lung allocation." The Journal of Heart and Lung Transplantation 30.4 (2011): 426-434.
  55. Yamada, Yoshito, et al. "Impact of human leukocyte antigen mismatch on lung transplant outcome." Interactive cardiovascular and thoracic surgery 26.5 (2018): 859-864.
  56. Smith, John D., et al. "Pre-transplant donor HLA-specific antibodies: characteristics causing detrimental effects on survival after lung transplantation." The Journal of Heart and Lung Transplantation 33.10 (2014): 1074-1082.
  57. Gaissert, Henning A., et al. "Comparison of early functional results after volume reduction or lung transplantation for chronic obstructive pulmonary disease." The Journal of Thoracic and Cardiovascular Surgery 111.2 (1996): 296-307.
  58. Stillwell, Paul C., and George B. Mallory Jr. "Pediatric lung transplantation." Clinics in chest medicine 18.2 (1997): 405-414.
  59. Grossman, R. F., et al. "Results of single-lung transplantation for bilateral pulmonary fibrosis." New England Journal of Medicine 322.11 (1990): 727-733.
  60. Sharples, L., et al. "Prognosis of patients with cystic fibrosis awaiting heart and lung transplantation." The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation 12.4 (1993): 669-674.
  61. Luong, Me-Linh, Orla Morrissey, and Shahid Husain. "Assessment of infection risks prior to lung transplantation." Current opinion in infectious diseases 23.6 (2010): 578-583.
  62. Richter, Manuel J., et al. "The prognostic impact of thyroid function in pulmonary hypertension." The Journal of Heart and Lung Transplantation 35.12 (2016): 1427-1434.
  63. Nowak, J., et al. "Role of pro-brain natriuretic peptide serum concentration in the detection of pulmonary hypertension in patients with end-stage lung diseases referred for lung transplantation." Transplantation Proceedings. Vol. 50. No. 7. Elsevier, 2018.
  64. Ploegstra M. J., Berger R. M. F. Prognostic biomarkers in pediatric pulmonary arterial hypertension //Cardiovascular diagnosis and therapy. – 2021. – Т. 11. – №. 4. – С. 1089.
  65. Bı̂rsan, Tudor, et al. "Transient left ventricular failure following bilateral lung transplantation for pulmonary hypertension." The Journal of heart and lung transplantation 18.4 (1999): 304-309.
  66. Leard, Lorriana E., et al. "Consensus document for the selection of lung transplant candidates: an update from the International Society for Heart and Lung Transplantation." The Journal of Heart and Lung Transplantation 40.11 (2021): 1349-1379.
  67. Ochman M. et al. Lung transplantation as a viable option of treatment for pulmonary veno-occlusive disease //Advances in respiratory medicine. – 2018. – Т. 86. – №. 5. – С. 249-254.
  68. Holcomb Jr, Barry W., et al. "Pulmonary veno-occlusive disease: a case series and new observations." Chest 118.6 (2000): 1671-1679.
  69. Pooja P., Vinita A. Significance of six minute walk test (6MWT) in COPD patients //Work. – 2017. – Т. 32. – С. 0.0001.
  70. Fernández Fabrellas E. et al. Prognosis and follow-up of idiopathic pulmonary fibrosis //Medical Sciences. – 2018. – Т. 6. – №. 2. – С. 51.
  71. Kumar A. et al. Lung transplantation in idiopathic pulmonary fibrosis //Expert review of respiratory medicine. – 2018. – Т. 12. – №. 5. – С. 375-385.
  72. Thabut G. et al. Survival benefit of lung transplantation for patients with idiopathic pulmonary fibrosis //The Journal of thoracic and cardiovascular surgery. – 2003. – Т. 126. – №. 2. – С. 469-475.
  73. Kistler K. D. et al. Lung transplantation in idiopathic pulmonary fibrosis: a systematic review of the literature //BMC pulmonary medicine. – 2014. – Т. 14. – №. 1. – С. 139.
  74. Milla C. E., Warwick W. J. Risk of death in cystic fibrosis patients with severely compromised lung function //Chest. – 1998. – Т. 113. – №. 5. – С. 1230-1234.
  75. Liou T. G. et al. Survival effect of lung transplantation among patients with cystic fibrosis //Jama. – 2001. – Т. 286. – №. 21. – С. 2683-2689.
  76. Tuppin M. P. et al. Predictive utility of the 6-minute walk distance on survival in patients awaiting lung transplantation //The Journal of heart and lung transplantation. – 2008. – Т. 27. – №. 7. – С. 729-734.
  77. Chaparro, Cecilia, et al. "Infection with Burkholderia cepacia in cystic fibrosis: outcome following lung transplantation." American journal of respiratory and critical care medicine 163.1 (2001): 43-48.
  78. Ramos K. J. et al. Heterogeneity in survival in adult patients with cystic fibrosis with FEV1< 30% of predicted in the United States //Chest. – 2017. – Т. 151. – №. 6. – С. 1320-1328.
  79. Hayes Jr D. et al. Mortality risk and pulmonary function in adults with cystic fibrosis at time of wait listing for lung transplantation //The Annals of Thoracic Surgery. – 2015. – Т. 100. – №. 2. – С. 474-479.
  80. Lehr C. J. et al. Effect of including important clinical variables on accuracy of the lung allocation score for cystic fibrosis and chronic obstructive pulmonary disease //American journal of respiratory and critical care medicine. – 2019. – Т. 200. – №. 8. – С. 1013-1021.
  81. Belkin R. A. et al. Risk factors for death of patients with cystic fibrosis awaiting lung transplantation //American journal of respiratory and critical care medicine. – 2006. – Т. 173. – №. 6. – С. 659-666.
  82. Solé A. et al. Patient-reported symptoms and functioning as indicators of mortality in advanced cystic fibrosis: A new tool for referral and selection for lung transplantation //The Journal of Heart and Lung Transplantation. – 2016. – Т. 35. – №. 6. – С. 789-794.
  83. Hayes Jr D. et al. Pulmonary hypertension in cystic fibrosis with advanced lung disease //American journal of respiratory and critical care medicine. – 2014. – Т. 190. – №. 8. – С. 898-905.
  84. Hayes Jr D. et al. Pulmonary artery pressure and benefit of lung transplantation in adult cystic fibrosis patients //The Annals of Thoracic Surgery. – 2016. – Т. 101. – №. 3. – С. 1104-1109.
  85. Lord R. W. et al. Pneumothorax in cystic fibrosis: beyond the guidelines //Paediatric Respiratory Reviews. – 2016. – Т. 20. – С. 30-33.
  86. de Boer K. et al. Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis //Thorax. – 2011. – Т. 66. – №. 8. – С. 680-685.
  87. Nkam L. et al. A 3-year prognostic score for adults with cystic fibrosis //Journal of Cystic Fibrosis. – 2017. – Т. 16. – №. 6. – С. 702-708.
  88. Flight W. G. et al. Outcomes following bronchial artery embolisation for haemoptysis in cystic fibrosis //CardioVascular and Interventional Radiology. – 2017. – Т. 40. – №. 8. – С. 1164-1168.
  89. Flume P. A. et al. Massive hemoptysis in cystic fibrosis //Chest. – 2005. – Т. 128. – №. 2. – С. 729-738.
  90. Town J. A., Monroe E. J., Aitken M. L. Deaths related to bronchial arterial embolization in patients with cystic fibrosis: three cases and an institutional review //Chest. – 2016. – Т. 150. – №. 4. – С. e93-e98.
  91. Kerem E. et al. Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS patient registry //European Respiratory Journal. – 2014. – Т. 43. – №. 1. – С. 125-133.
  92. Martin C. et al. Prognostic value of six minute walk test in cystic fibrosis adults //Respiratory medicine. – 2013. – Т. 107. – №. 12. – С. 1881-1887.
  93. Robinson W., Waltz D. A. FEV1 as a guide to lung transplant referral in young patients with cystic fibrosis //Pediatric pulmonology. – 2000. – Т. 30. – №. 3. – С. 198-202.
  94. Benden, Christian. "Specific aspects of children and adolescents undergoing lung transplantation." Current opinion in organ transplantation 17.5 (2012): 509-514.
  95. Chernenko, Susan M., et al. "Mycobacterium abscessus infections in lung transplant recipients: the international experience." The Journal of heart and lung transplantation 25.12 (2006): 1447-1455
  96. Raats D. et al. Successful lung transplantation for chronic Mycobacterium abscessus infection in advanced cystic fibrosis, a case series //Transplant Infectious Disease. – 2019. – Т. 21. – №. 2. – С. e13046.
  97. Lobo, Leonard J., et al. "Lung transplant outcomes in cystic fibrosis patients with pre‐operative M ycobacterium abscessus respiratory infections." Clinical transplantation 27.4 (2013): 523-529.
  98. Olivier, Kenneth N., et al. "Randomized trial of liposomal amikacin for inhalation in nontuberculous mycobacterial lung disease // American journal of respiratory and critical care medicine 195.6 (2017): 814-823.
  99. Osmani M. et al. Mycobacterium abscessus infections in lung transplant recipients: 15‐year experience from a single institution //Transplant Infectious Disease. – 2018. – Т. 20. – №. 2. – С. e12835.
  100. Knoll B. M. et al. Non‐tuberculous mycobacterial infection among lung transplant recipients: a 15‐year cohort study //Transplant Infectious Disease. – 2012. – Т. 14. – №. 5. – С. 452-460.
  101. Longworth S. A. et al. Risk factors for nontuberculous mycobacterial infections in solid organ transplant recipients: a case–control study //Transplant Infectious Disease. – 2014. – Т. 16. – №. 1. – С. 76-83.
  102. Vandamme, Peter, et al. "Occurrence of Multiple Genomovars of Burkholderia cepacia in Cystic Fibrosis Patients and Proposal of Burkholderia multivorans sp. nov." International Journal of Systematic and Evolutionary Microbiology 47.4 (1997): 1188-1200.
  103. Mariencheck Jr, W. I., et al. "Survival following lung transplantation of cystic fibrosis patients colonized with Burkholderia cepacia // Am J Respir Crit Care Med 161 (2000): 720.
  104. De Soyza, Anthony, et al. "Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis." The Lancet 358.9295 (2001): 1780-1781.
  105. ARIS, ROBERT M., et al. "Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex: survival linked to genomovar type // American journal of respiratory and critical care medicine 164.11 (2001): 2102-2106.
  106. Coenye, Tom, et al. "Burkholderia cepacia genomovar VI, a new member of the Burkholderia cepacia complex isolated from cystic fibrosis patients." International Journal of Systematic and Evolutionary Microbiology 51.2 (2001): 271-279.
  107. Meachery, G. J., et al. "185: Survival outcomes following lung transplantation for cystic fibrosis patients infected with Burkholderia cenocepacia–a UK experience." The Journal of Heart and Lung Transplantation 26.2 (2007): S126-S127.
  108. Murray S. et al. Impact of Burkholderia infection on lung transplantation in cystic fibrosis //American journal of respiratory and critical care medicine. – 2008. – Т. 178. – №. 4. – С. 363-371.
  109. Carraro, D. S., et al. "Study of Burkholderia Cepacia Complex Strains in Lung Transplant Patients: Analysis of Genomovar and Mortality Impact." The Journal of Heart and Lung Transplantation 33.4 (2014): S182.
  110. Lay, Cecilia, et al. "Outcomes in cystic fibrosis lung transplant recipients infected with organisms labeled as pan-resistant: An ISHLT Registry‒based analysis." The Journal of Heart and Lung Transplantation 38.5 (2019): 545-552.
  111. Boussaud V. et al. Clinical outcome following lung transplantation in patients with cystic fibrosis colonised with Burkholderia cepacia complex: results from two French centres //Thorax. – 2008. – Т. 63. – №. 8. – С. 732-737.
  112. Blatter, Joshua, and Stuart Sweet. "Lung transplantation in cystic fibrosis: trends and controversies //Pediatric allergy, immunology, and pulmonology 28.4 (2015): 237-243.
  113. López-Meseguer M. et al. Lung and heart-lung transplantation in pulmonary arterial hypertension //PloS one. – 2017. – Т. 12. – №. 11. – С. e0187811.
  114. Le Pavec J., Hascoët S., Fadel E. Heart-lung transplantation: current indications, prognosis and specific considerations //Journal of Thoracic Disease. – 2018. – Т. 10. – №. 10. – С. 5946.
  115. Choong C. K. et al. Repair of congenital heart lesions combined with lung transplantation for the treatment of severe pulmonary hypertension: a 13-year experience //The Journal of Thoracic and Cardiovascular Surgery. – 2005. – Т. 129. – №. 3. – С. 661-669.
  116. Januszewska K. et al. Heart–lung transplantation in patients with pulmonary atresia and ventricular septal defect //The Journal of thoracic and cardiovascular surgery. – 2009. – Т. 138. – №. 3. – С. 738-743.
  117. Huddleston C. B., Richey S. R. Heart-lung transplantation //Journal of thoracic disease. – 2014. – Т. 6. – №. 8. – С. 1150.
  118. Hjortshøj C. S. et al. Outcome after heart–lung or lung transplantation in patients with Eisenmenger syndrome //Heart. – 2020. – Т. 106. – №. 2. – С. 127-132.
  119. Toyoda Y., Toyoda Y. Heart-lung transplantation: adult indications and outcomes //Journal of thoracic disease. – 2014. – Т. 6. – №. 8. – С. 1138.
  120. Khush K. K. et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-fifth adult heart transplantation report—2018; focus theme: multiorgan transplantation //The Journal of Heart and Lung Transplantation. – 2018. – Т. 37. – №. 10. – С. 1155-1168.
  121. Fadel E. et al. Long-term outcome of double-lung and heart–lung transplantation for pulmonary hypertension: a comparative retrospective study of 219 patients //European journal of cardio-thoracic surgery. – 2010. – Т. 38. – №. 3. – С. 277-284.
  122. Sottile P. D. et al. Outcomes in systemic sclerosis-related lung disease following lung transplantation //Transplantation. – 2013. – Т. 95. – №. 7. – С. 975.
  123. Bernstein E. J. et al. Survival of adults with systemic sclerosis following lung transplantation: a nationwide cohort study //Arthritis & rheumatology. – 2015. – Т. 67. – №. 5. – С. 1314-1322.
  124. Strek M. E. Systemic sclerosis‐associated interstitial lung disease: Role of the oesophagus in outcomes //Respirology. – 2018. – Т. 23. – №. 10. – С. 885-886.
  125. Eberlein M., Mathai S. C. Lung transplantation in scleroderma. Time for the pendulum to swing?. – 2016.
  126. Chan E. Y. et al. Long-term survival in bilateral lung transplantation for scleroderma-related lung disease //The Annals of Thoracic Surgery. – 2018. – Т. 105. – №. 3. – С. 893-900.
  127. Crespo M. M. et al. Lung transplant in patients with scleroderma compared with pulmonary fibrosis. Short-and long-term outcomes //Annals of the American Thoracic Society. – 2016. – Т. 13. – №. 6. – С. 784-792.
  128. Pradère P. et al. Lung transplantation for scleroderma lung disease: an international, multicenter, observational cohort study //The Journal of Heart and Lung Transplantation. – 2018. – Т. 37. – №. 7. – С. 903-911.
  129. Чиссов В. И. Онкология: нац. рук. – ГЭОТАР-Медиа, 2008.
  130. Zorn Jr G. L. et al. Pulmonary transplantation for advanced bronchioloalveolar carcinoma //The Journal of thoracic and cardiovascular surgery. – 2003. – Т. 125. – №. 1. – С. 45-48.
  131. Kachala S. S., Murthy S. C. Lung transplantation for multifocal lung adenocarcinoma (multifocal lung carcinoma) //Thoracic Surgery Clinics. – 2014. – Т. 24. – №. 4. – С. 485-491.
  132. de Perrot M. et al. Role of lung transplantation in the treatment of bronchogenic carcinomas for patients with end-stage pulmonary disease //Journal of clinical oncology. – 2004. – Т. 22. – №. 21. – С. 4351-4356.
  133. Brand T., Haithcock B. Lung cancer and lung transplantation //Thoracic Surgery in the Special Care Patient, An Issue of Thoracic Surgery Clinics, E-Book. – 2017. – Т. 28. – №. 1. – С. 15-18.
  134. Glanville A. R., Wilson B. E. Lung transplantation for non-small cell lung cancer and multifocal bronchioalveolar cell carcinoma //The Lancet Oncology. – 2018. – Т. 19. – №. 7. – С. e351-e358.
  135. Machuca T. N., Keshavjee S. Transplantation for lung cancer //Current opinion in organ transplantation. – 2012. – Т. 17. – №. 5. – С. 479-484.
  136. Klikovits T. et al. Lung transplantation in patients with incidental early stage lung cancer—institutional experience of a high volume center //Clinical transplantation. – 2016. – Т. 30. – №. 8. – С. 912-917.
  137. Ahmad U. et al. Outcomes for lung transplantation for lung cancer in the United Network for Organ Sharing Registry //The Annals of thoracic surgery. – 2012. – Т. 94. – №. 3. – С. 935-941.
  138. Paloyan E. B. et al. Lung transplantation for advanced bronchioloalveolar carcinoma confined to the lungs //Transplantation. – 2000. – Т. 69. – №. 11. – С. 2446-2448.
  139. Mathew J., Kratzke R. A. Lung cancer and lung transplantation: a review //Journal of Thoracic Oncology. – 2009. – Т. 4. – №. 6. – С. 753-760.
  140. Benden C. Pediatric lung transplantation //Journal of thoracic disease. – 2017. – Т. 9. – №. 8. – С. 2675.
  141. Spray T. L. et al. Pediatric lung transplantation: indications, techniques, and early results //The Journal of Thoracic and Cardiovascular Surgery. – 1994. – Т. 107. – №. 4. – С. 990-1000.
  142. Blatter J. A., Noyes B., Sweet S. C. Pediatric lung transplantation //Kendig"s Disorders of the Respiratory Tract in Children. – Content Repository Only!, 2019. – С. 981-991. e4.
  143. Schmid F. A., Benden C. Special considerations for the use of lung transplantation in pediatrics //Expert Review of Respiratory Medicine. – 2016. – Т. 10. – №. 6. – С. 655-662.
  144. Khan M. S. et al. Is lung transplantation survival better in infants? Analysis of over 80 infants //The Journal of Heart and Lung Transplantation. – 2013. – Т. 32. – №. 1. – С. 44-49.
  145. Soares J. J. et al. Childhood interstitial lung diseases: an 18-year retrospective analysis //Pediatrics. – 2013. – Т. 132. – №. 4. – С. 684-691.
  146. Benoit T. M., Benden C. Pediatric lung transplantation: supply and demand //Current opinion in organ transplantation. – 2019. – Т. 24. – №. 3. – С. 324-328.
  147. Eldridge W. B. et al. Outcomes of lung transplantation for infants and children with genetic disorders of surfactant metabolism //The Journal of pediatrics. – 2017. – Т. 184. – С. 157-164. e2.
  148. Dellon E. et al. Pediatric lung transplantation and end of life care in cystic fibrosis: Barriers and successful strategies //Pediatric Pulmonology. – 2017. – Т. 52. – №. S48. – С. S61-S68.
  149. Riggs K. W. et al. Pediatric heart‐lung transplantation: A contemporary analysis of outcomes //Pediatric Transplantation. – 2020. – Т. 24. – №. 3. – С. e13682.
  150. Novick R. J., Stitt L. Pulmonary retransplantation //Seminars in thoracic and cardiovascular surgery. – WB Saunders, 1998. – Т. 10. – №. 3. – С. 227-236.
  151. Roy S. B. et al. Lung retransplantation for chronic rejection: a single-center experience //The Annals of Thoracic Surgery. – 2018. – Т. 105. – №. 1. – С. 221-227.
  152. Doyle S. et al. Predictive Utility of Lung Allocation Score for Retransplantation Outcomes //The Annals of thoracic surgery. – 2018. – Т. 106. – №. 5. – С. 1525-1532.
  153. Brugieère O. et al. Lung retransplantation for bronchiolitis obliterans syndrome: long-term follow-up in a series of 15 recipients //Chest. – 2003. – Т. 123. – №. 6. – С. 1832-1837.
  154. Kawut S. M. et al. Outcomes after lung retransplantation in the modern era //American journal of respiratory and critical care medicine. – 2008. – Т. 177. – №. 1. – С. 114-120.
  155. Kawut S. M. Lung retransplantation //Clinics in chest medicine. – 2011. – Т. 32. – №. 2. – С. 367-377.
  156. Hall D. J. et al. Two decades of lung retransplantation: a single-center experience //The Annals of thoracic surgery. – 2017. – Т. 103. – №. 4. – С. 1076-1083.
  157. Ren D. et al. Retransplantation outcomes at a large lung transplantation program //Transplantation Direct. – 2018. – Т. 4. – №. 11.
  158. Lindstedt S. et al. Pulmonary retransplantation in the Nordic countries //The Annals of Thoracic Surgery. – 2015. – Т. 99. – №. 5. – С. 1781-1787.
  159. Strueber M. et al. Long-term outcome after pulmonary retransplantation //The Journal of thoracic and cardiovascular surgery. – 2006. – Т. 132. – №. 2. – С. 407-412.
  160. Aigner C. Retransplantation //Current opinion in organ transplantation. – 2015. – Т. 20. – №. 5. – С. 521-526.
  161. Wigfield C. H., Buie V., Onsager D. “Age” in lung transplantation: factors related to outcomes and other considerations //Current pulmonology reports. – 2016. – Т. 5. – №. 3. – С. 152-158.
  162. Courtwright A., Cantu E. Lung transplantation in elderly patients //Journal of thoracic disease. – 2017. – Т. 9. – №. 9. – С. 3346.
  163. Hayanga A. J. et al. Contemporary analysis of early outcomes after lung transplantation in the elderly using a national registry //The Journal of Heart and Lung Transplantation. – 2015. – Т. 34. – №. 2. – С. 182-188.
  164. Roy S. B. et al. Is there an age limit to lung transplantation? //The Annals of thoracic surgery. – 2015. – Т. 100. – №. 2. – С. 443-451.
  165. Black S. M. et al. Influence of donor and recipient age in lung transplantation //J Heart Lung Transplant. – 2015. – Т. 34. – №. 1. – С. 43-49.
  166. Madill J. et al. Nutritional assessment of the lung transplant patient: body mass index as a predictor of 90–day mortality following transplantation //The Journal of heart and lung transplantation. – 2001. – Т. 20. – №. 3. – С. 288-296.
  167. Lederer D. J. et al. Obesity and underweight are associated with an increased risk of death after lung transplantation //American journal of respiratory and critical care medicine. – 2009. – Т. 180. – №. 9. – С. 887-895.
  168. Kanasky Jr W. F. et al. Impact of body weight on long-term survival after lung transplantation //Chest. – 2002. – Т. 121. – №. 2. – С. 401-406.
  169. Singer J. P. et al. Body composition and mortality after adult lung transplantation in the United States //American journal of respiratory and critical care medicine. – 2014. – Т. 190. – №. 9. – С. 1012-1021.
  170. Upala S. et al. Underweight and obesity increase the risk of mortality after lung transplantation: a systematic review and meta‐analysis //Transplant International. – 2016. – Т. 29. – №. 3. – С. 285-296.
  171. Bozso S. J. et al. Impact of obesity on heart and lung transplantation: does pre-transplant obesity affect outcomes? //Transplantation Proceedings. – Elsevier, 2017. – Т. 49. – №. 2. – С. 344-347.
  172. Førli L. et al. The influence of underweight and dietary support on well-being in lung transplant candidates //Respiratory medicine. – 2006. – Т. 100. – №. 7. – С. 1239-1246.
  173. Komatsu T. et al. Severe underweight decreases the survival rate in adult lung transplantation //Surgery today. – 2017. – Т. 47. – №. 10. – С. 1243-1248.
  174. Ruttens D. et al. Body mass index in lung transplant candidates: a contra-indication to transplant or not? //Transplantation proceedings. – Elsevier, 2014. – Т. 46. – №. 5. – С. 1506-1510.
  175. Ramos K. J. et al. Underweight patients with cystic fibrosis have acceptable survival following lung transplantation: a united network for organ sharing registry study //Chest. – 2020.
  176. Aris R. M. et al. Severe osteoporosis before and after lung transplantation //Chest. – 1996. – Т. 109. – №. 5. – С. 1176-1183.
  177. Shane E. et al. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease //The American journal of medicine. – 1996. – Т. 101. – №. 3. – С. 262-269.
  178. Spira A. et al. Osteoporosis and lung transplantation: a prospective study //Chest. – 2000. – Т. 117. – №. 2. – С. 476-481.
  179. Tschopp O. et al. Osteoporosis before lung transplantation: association with low body mass index, but not with underlying disease //American journal of transplantation. – 2002. – Т. 2. – №. 2. – С. 167-172.
  180. Lakey W. C. et al. Osteoporosis in lung transplant candidates compared to matched healthy controls //Clinical transplantation. – 2011. – Т. 25. – №. 3. – С. 426-435.
  181. Detterbeck F. C., Egan T. M., Mill M. R. Lung transplantation after previous thoracic surgical procedures //The Annals of thoracic surgery. – 1995. – Т. 60. – №. 1. – С. 139-143.
  182. Curtis H. J. et al. Lung transplantation outcome in cystic fibrosis patients with previous pneumothorax //The Journal of heart and lung transplantation. – 2005. – Т. 24. – №. 7. – С. 865-869.
  183. Shigemura N. et al. Lung transplantation in patients with prior cardiothoracic surgical procedures //American Journal of Transplantation. – 2012. – Т. 12. – №. 5. – С. 1249-1255.
  184. Omara M. et al. Lung transplantation in patients who have undergone prior cardiothoracic procedures //The Journal of Heart and Lung Transplantation. – 2016. – Т. 35. – №. 12. – С. 1462-1470.
  185. Thibodeau A. Mechanical pleurodesis is not a contraindication to lung transplantation //Clinical Research in Practice: The Journal of Team Hippocrates. – 2018. – Т. 4. – №. 1. – С. 5.
  186. Leard L. E. Lung transplantation after prior cardiothoracic surgery: To transplant or not to transplant //The Journal of Heart and Lung Transplantation. – 2016. – Т. 35. – №. 11. – С. 1284-1285.
  187. Hinske L. C. et al. Predicting the necessity for extracorporeal circulation during lung transplantation: a feasibility study //Journal of cardiothoracic and vascular anesthesia. – 2017. – Т. 31. – №. 3. – С. 931-938.
  188. Shah P. R. et al. Extracorporeal support during bilateral sequential lung transplantation in patients with pulmonary hypertension: Risk Factors and Outcomes //Journal of Cardiothoracic and Vascular Anesthesia. – 2017. – Т. 31. – №. 2. – С. 418-425.
  189. Bermudez C. A. et al. Extracorporeal membrane oxygenation as a bridge to lung transplant: midterm outcomes //The Annals of thoracic surgery. – 2011. – Т. 92. – №. 4. – С. 1226-1232.
  190. Biscotti M., Sonett J., Bacchetta M. ECMO as bridge to lung transplant //Thoracic Surgery Clinics. – 2015. – Т. 25. – №. 1. – С. 17-25.
  191. Todd E. M. et al. Extracorporeal membrane oxygenation as a bridge to lung transplantation: a single-center experience in the present era //The Journal of thoracic and cardiovascular surgery. – 2017. – Т. 154. – №. 5. – С. 1798-1809.
  192. Bartz R. R. et al. Pre-transplant mechanical ventilation and outcome in patients with cystic fibrosis //The Journal of heart and lung transplantation. – 2003. – Т. 22. – №. 4. – С. 433-438.
  193. Hamilton B. C. et al. Improved Survival After Lung Transplantation for Adults Requiring Pre-Operative Invasive Mechanical Ventilation: A National Cohort Study //The Journal of Heart and Lung Transplantation. – 2017. – Т. 36. – №. 4. – С. S94-S95.
  194. Vermeijden J. W. et al. Lung transplantation for ventilator-dependent respiratory failure //The Journal of heart and lung transplantation. – 2009. – Т. 28. – №. 4. – С. 347-351.
  195. Benazzo A. et al. Twenty-year experience with extracorporeal life support as bridge to lung transplantation //The Journal of thoracic and cardiovascular surgery. – 2019. – Т. 157. – №. 6. – С. 2515-2525. e10.
  196. García-Gigorro R. et al. Mechanical support with venoarterial extracorporeal membrane oxygenation (ECMO-VA): Short-term and long-term prognosis after a successful weaning //Medicina Intensiva (English Edition). – 2017. – Т. 41. – №. 9. – С. 513-522.
  197. Clajus C. et al. Therapeutic approach to respiratory infections in lung transplantation //Pulmonary pharmacology & therapeutics. – 2015. – Т. 32. – С. 149-154.
  198. Nishi S. P. E., Valentine V. G., Duncan S. Emerging bacterial, fungal, and viral respiratory infections in transplantation //Infectious Disease Clinics. – 2010. – Т. 24. – №. 3. – С. 541-555.
  199. Vazquez R. et al. Invasive mold infections in lung and heart‐lung transplant recipients: Stanford University experience //Transplant Infectious Disease. – 2015. – Т. 17. – №. 2. – С. 259-266.
  200. Geltner C., Lass-Flörl C. Invasive pulmonary Aspergillosis in organ transplants–Focus on lung transplants //Respiratory Investigation. – 2016. – Т. 54. – №. 2. – С. 76-84.
  201. Kennedy C. C., Razonable R. R. Fungal infections after lung transplantation //Clinics in chest medicine. – 2017. – Т. 38. – №. 3. – С. 511-520.
  202. Clark N. M. et al. Fungal infections complicating lung transplantation //Seminars in respiratory and critical care medicine. – Thieme Medical Publishers, 2018. – Т. 39. – №. 02. – С. 227-254.
  203. Stamenkovic S. A. et al. Recurrence of hepatitis B after single lung transplantation //The Journal of heart and lung transplantation. – 1999. – Т. 18. – №. 12. – С. 1246-1250.
  204. Hosenpud J. D. et al. Outcomes in patients who are hepatitis B surface antigen–positive before transplantation: an analysis and study using the joint ISHLT/UNOS thoracic registry //The Journal of heart and lung transplantation. – 2000. – Т. 19. – №. 8. – С. 781-785.
  205. Large S. R. Impact of hepatitis B core antibody positive donors in lung and heart-lung transplantation: an analysis of the UNOS database //Transplantation. – 2009. – Т. 88. – №. 6. – С. 759.
  206. Galar A. et al. Serologic response to hepatitis B vaccination among lung transplantation candidates //Transplantation. – 2014. – Т. 98. – №. 6. – С. 676-679.
  207. Doucette K. E. et al. Outcomes of lung transplantation in recipients with hepatitis C virus infection //American Journal of Transplantation. – 2016. – Т. 16. – №. 8. – С. 2445-2452.
  208. Koenig A. et al. Long‐term outcomes of lung transplant recipients with hepatitis C infection: a retrospective study of the US transplant registry //Alimentary pharmacology & therapeutics. – 2016. – Т. 44. – №. 3. – С. 271-278.
  209. Bertani A. et al. Successful lung transplantation in an HIV‐and HBV‐positive patient with cystic fibrosis //American Journal of Transplantation. – 2009. – Т. 9. – №. 9. – С. 2190-2196.
  210. George M. P. Time to reconsider transplant criteria for candidacy? Lung transplantation feasibility in HIV-infected patients. – 2014.
  211. Kern R. M. et al. The feasibility of lung transplantation in HIV-seropositive patients //Annals of the American Thoracic Society. – 2014. – Т. 11. – №. 6. – С. 882-889.
  212. Blumberg E. A., Rogers C. C., American Society of Transplantation Infectious Diseases Community of Practice. Solid organ transplantation in the HIV‐infected patient: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice //Clinical transplantation. – 2019. – Т. 33. – №. 9. – С. e13499.
  213. ARIS R. M. et al. Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex: survival linked to genomovar type //American journal of respiratory and critical care medicine. – 2001. – Т. 164. – №. 11. – С. 2102-2106.
  214. De Soyza A. et al. Lung transplantation for patients with cystic fibrosis and Burkholderia cepacia complex infection: a single-center experience //The Journal of Heart and Lung Transplantation. – 2010. – Т. 29. – №. 12. – С. 1395-1404.
  215. Wang R. et al. Survival after lung transplantation of cystic fibrosis patients infected with Burkholderia dolosa (genomovar VI) //Clinical Transplantation. – 2018. – Т. 32. – №. 5. – С. e13236.
  216. Bills H. et al. Mycobacterium abscessus and lung transplantation: an international survey //The Journal of Heart and Lung Transplantation. – 2015. – Т. 34. – №. 4. – С. S304.
  217. Bradbury R. A. et al. Prior diabetes mellitus is associated with increased morbidity in cystic fibrosis patients undergoing bilateral lung transplantation: an ‘orphan’area? A retrospective case–control study //Internal medicine journal. – 2009. – Т. 39. – №. 6. – С. 384-388.
  218. Hackman K. L. et al. Diabetes is a major risk factor for mortality after lung transplantation //American Journal of Transplantation. – 2014. – Т. 14. – №. 2. – С. 438-445.
  219. Živković S. A. et al. Neurologic complications following lung transplantation //Journal of the neurological sciences. – 2009. – Т. 280. – №. 1-2. – С. 90-93.
  220. Mateen F. J. et al. Neurological complications following adult lung transplantation //American Journal of Transplantation. – 2010. – Т. 10. – №. 4. – С. 908-914.
  221. Gamez J. et al. Influence of early neurological complications on clinical outcome following lung transplant //PloS one. – 2017. – Т. 12. – №. 3. – С. e0174092.
  222. Goldstein L. S. et al. Central nervous system complications after lung transplantation //The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation. – 1998. – Т. 17. – №. 2. – С. 185-191.
  223. Lipson D. A. et al. Giant gastric ulcers and risk factors for gastroduodenal mucosal disease in orthotopic lung transplant patients //Digestive diseases and sciences. – 1998. – Т. 43. – №. 6. – С. 1177-1185.
  224. Hadjiliadis D. et al. Gastroesophageal reflux disease in lung transplant recipients //Clinical transplantation. – 2003. – Т. 17. – №. 4. – С. 363-368.
  225. Sweet M. P. et al. Gastroesophageal reflux in patients with idiopathic pulmonary fibrosis referred for lung transplantation //The Journal of Thoracic and Cardiovascular Surgery. – 2007. – Т. 133. – №. 4. – С. 1078-1084.
  226. Blondeau K. et al. Gastro-oesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection //European Respiratory Journal. – 2008. – Т. 31. – №. 4. – С. 707-713.
  227. Rudasill S. E. et al. Understanding lung transplant listing practices: Survival in lung transplant candidates who improve clinically to delisting //Surgery. – 2019. – Т. 166. – №. 6. – С. 1142-1147.
  228. Keeshan B. C. et al. Lung transplant waitlist mortality: height as a predictor of poor outcomes //Pediatric Transplantation. – 2015. – Т. 19. – №. 3. – С. 294-300.
  229. Smits J. M. et al. Evaluation of the lung allocation score in highly urgent and urgent lung transplant candidates in Eurotransplant //The Journal of heart and lung transplantation. – 2011. – Т. 30. – №. 1. – С. 22-28.
  230. Colman R. et al. Outcomes of lung transplant candidates referred for co-management by palliative care: a retrospective case series //Palliative medicine. – 2015. – Т. 29. – №. 5. – С. 429-435.
  231. Smith C. M. Patient selection, evaluation, and preoperative management for lung transplant candidates //Clinics in chest medicine. – 1997. – Т. 18. – №. 2. – С. 183-197.
  232. De Meester J. et al. Lung transplant waiting list: differential outcome of type of end-stage lung disease, one year after registration //The Journal of heart and lung transplantation. – 1999. – Т. 18. – №. 6. – С. 563-571.
  233. Maurer J. R. Indications, selection and pretransplant management of the potential recipient //The Transplantation and Replacement of Thoracic Organs. – Springer, Dordrecht, 1996. – С. 433-441.
  234. Guggenheimer J., Eghtesad B., Stock D. J. Dental management of the (solid) organ transplant patient //Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. – 2003. – Т. 95. – №. 4. – С. 383-389.
  235. Walterspacher S. et al. Dental care before lung transplantation: are we being too rigorous? //The clinical respiratory journal. – 2013. – Т. 7. – №. 2. – С. 220-225.
  236. Marcinkowski A. et al. Deficits in oral health behavior and oral health status in patients after lung transplantation //The Clinical Respiratory Journal. – 2018. – Т. 12. – №. 2. – С. 721-730.
  237. Schmalz G. et al. Oral health related quality of life depending on oral health and specific factors in patients after lung transplantation //The clinical respiratory journal. – 2018. – Т. 12. – №. 2. – С. 731-737.
  238. Melkos A. B. et al. Organ transplantation-assessment of dental procedures //Oral Biosci Med. – 2005. – Т. 4. – С. 259-64.
  239. Nosotti M. et al. Extracorporeal membrane oxygenation with spontaneous breathing as a bridge to lung transplantation //Interactive cardiovascular and thoracic surgery. – 2013. – Т. 16. – №. 1. – С. 55-59.
  240. Lafarge M. et al. Experience of extracorporeal membrane oxygenation as a bridge to lung transplantation in France //The Journal of Heart and Lung Transplantation. – 2013. – Т. 32. – №. 9. – С. 905-913.
  241. Hamilton B. C. S. et al. Improved survival after lung transplantation for adults requiring pre-operative invasive mechanical ventilation: A national cohort study //The Journal of Thoracic and Cardiovascular Surgery. – 2020.
  242. Feldman D. et al. The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary //The Journal of Heart and Lung Transplantation. – 2013. – Т. 32. – №. 2. – С. 157-187.
  243. Bando K. et al. Indications for and results of single, bilateral, and heart-lung transplantation for pulmonary hypertension //The Journal of thoracic and cardiovascular surgery. – 1994. – Т. 108. – №. 6. – С. 1056-1065.
  244. Kendall S. W., Wallwork J. Heart-lung transplantation: indications and technique //Semin Thorac Cardiovasc Surg. – 1992. – Т. 4. – С. 101-106.
  245. Idrees J. J., Pettersson G. B. State of the art of combined heart-lung transplantation for advanced cardiac and pulmonary dysfunction //Current cardiology reports. – 2016. – Т. 18. – №. 4. – С. 36.
  246. Patterson G. A. INDICATIONS: Unilateral, Bilateral, Heart–Lung, and Lobar Transplant Procedures //Clinics in chest medicine. – 1997. – Т. 18. – №. 2. – С. 225-230.
  247. Calhoon J. H. et al. Single lung transplantation: alternative indications and technique //The Journal of thoracic and cardiovascular surgery. – 1991. – Т. 101. – №. 5. – С. 816-825.
  248. Waters P. F. Single lung transplant: Indications and technique //Semin Thorac Cardiovasc Surg. – 1992. – Т. 4. – С. 90-94.
  249. Brouckaert J. et al. Double‐lung versus heart‐lung transplantation for precapillary pulmonary arterial hypertension: a 24‐year single‐center retrospective study //Transplant International. – 2019. – Т. 32. – №. 7. – С. 717-729.
  250. Barlow C. W. et al. Heart-lung versus double-lung transplantation for suppurative lung disease //The Journal of thoracic and cardiovascular surgery. – 2000. – Т. 119. – №. 3. – С. 466-476.
  251. Bonnette P. Logistic, technic and postoperative complications of lung and heart-lung transplantations //Revue de Pneumologie clinique. – 2010. – Т. 67. – №. 1. – С. 15-20.
  252. Aigner C., Klepetko W. Bilateral lung transplantation //Operative Techniques in Thoracic and Cardiovascular Surgery. – 2012. – Т. 17. – №. 3. – С. 181-193.
  253. Patterson G. A. et al. Comparison of outcomes of double and single lung transplantation for obstructive lung disease //The Journal of thoracic and cardiovascular surgery. – 1991. – Т. 101. – №. 4. – С. 623-632.
  254. Low D. E. et al. Morbidity, mortality, and early results of single versus bilateral lung transplantation for emphysema //The Journal of thoracic and cardiovascular surgery. – 1992. – Т. 103. – №. 6. – С. 1119-1126.
  255. Bains M. S. et al. The clamshell incision: an improved approach to bilateral pulmonary and mediastinal tumor //The Annals of thoracic surgery. – 1994. – Т. 58. – №. 1. – С. 30-33.
  256. Luciani G. B., Starnes V. A. The clamshell approach for the surgical treatment of complex cardiopulmonary pathology in infants and children //European journal of cardio-thoracic surgery. – 1997. – Т. 11. – №. 2. – С. 298-306.
  257. Macchiarini P. et al. Clamshell or sternotomy for double lung or heart-lung transplantation? //European journal of cardio-thoracic surgery. – 1999. – Т. 15. – №. 3. – С. 333-339.
  258. Dark J. H. Median sternotomy for lung transplantation //Operative Techniques in Thoracic and Cardiovascular Surgery. – 2015. – Т. 20. – №. 1. – С. 87-103.
  259. Cooper J. D. et al. Technique of successful lung transplantation in humans //The Journal of thoracic and cardiovascular surgery. – 1987. – Т. 93. – №. 2. – С. 173-181.
  260. Hayanga J. W. A., D’Cunha J. The surgical technique of bilateral sequential lung transplantation //Journal of thoracic disease. – 2014. – Т. 6. – №. 8. – С. 1063.
  261. Boasquevisque C. H. R. et al. Surgical techniques: lung transplant and lung volume reduction //Proceedings of the American Thoracic Society. – 2009. – Т. 6. – №. 1. – С. 66-78.
  262. Gust L. et al. Single-lung and double-lung transplantation: technique and tips //Journal of thoracic disease. – 2018. – Т. 10. – №. 4. – С. 2508.
  263. Patterson G. A. Bilateral lung transplant: indications and technique //Semin Thorac Cardiovasc Surg. – 1992. – Т. 4. – №. 2. – С. 95-100.
  264. Oto T. et al. Extracorporeal membrane oxygenation after lung transplantation: evolving technique improves outcomes //The Annals of thoracic surgery. – 2004. – Т. 78. – №. 4. – С. 1230-1235.
  265. Aigner C. et al. Institutional experience with extracorporeal membrane oxygenation in lung transplantation //European journal of cardio-thoracic surgery. – 2007. – Т. 31. – №. 3. – С. 468-474.
  266. Ius F. et al. Five-year experience with intraoperative extracorporeal membrane oxygenation in lung transplantation: Indications and midterm results //The Journal of Heart and Lung Transplantation. – 2016. – Т. 35. – №. 1. – С. 49-58.
  267. Mulvihill M. S. et al. Extracorporeal membrane oxygenation following lung transplantation: indications and survival //The Journal of Heart and Lung Transplantation. – 2018. – Т. 37. – №. 2. – С. 259-267.
  268. Hoechter D. J. et al. Extracorporeal circulation during lung transplantation procedures: a meta-analysis //Asaio Journal. – 2017. – Т. 63. – №. 5. – С. 551-561.
  269. Ius F. et al. Lung transplantation on cardiopulmonary support: venoarterial extracorporeal membrane oxygenation outperformed cardiopulmonary bypass //The Journal of thoracic and cardiovascular surgery. – 2012. – Т. 144. – №. 6. – С. 1510-1516.
  270. Pereszlenyi A. et al. Bilateral lung transplantation with intra-and postoperatively prolonged ECMO support in patients with pulmonary hypertension //European journal of cardio-thoracic surgery. – 2002. – Т. 21. – №. 5. – С. 858-863.
  271. Machuca T. N. et al. Outcomes of intraoperative extracorporeal membrane oxygenation versus cardiopulmonary bypass for lung transplantation //The Journal of thoracic and cardiovascular surgery. – 2015. – Т. 149. – №. 4. – С. 1152-1157.
  272. Biscotti M. et al. Comparison of extracorporeal membrane oxygenation versus cardiopulmonary bypass for lung transplantation //The Journal of Thoracic and Cardiovascular Surgery. – 2014. – Т. 148. – №. 5. – С. 2410-2416.
  273. Bermudez C. A. et al. Outcomes of intraoperative venoarterial extracorporeal membrane oxygenation versus cardiopulmonary bypass during lung transplantation //The Annals of thoracic surgery. – 2014. – Т. 98. – №. 6. – С. 1936-1943.
  274. Lick S. D. et al. Technique of controlled reperfusion of the transplanted lung in humans //The Annals of thoracic surgery. – 2000. – Т. 69. – №. 3. – С. 910-912.
  275. Halldorsson A. et al. Controlled reperfusion after lung ischemia: implications for improved function after lung transplantation //The Journal of thoracic and cardiovascular surgery. – 1998. – Т. 115. – №. 2. – С. 415-425.
  276. Ahmad S., Shlobin O. A., Nathan S. D. Pulmonary complications of lung transplantation //Chest. – 2011. – Т. 139. – №. 2. – С. 402-411.
  277. Mulligan M. J. et al. The use of extended criteria donors decreases one-year survival in high-risk lung recipients: A review of the United Network of Organ Sharing Database //The Journal of thoracic and cardiovascular surgery. – 2016. – Т. 152. – №. 3. – С. 891-898. e2.
  278. Di Nardo, Matteo, et al. "Postoperative management of lung transplant recipients in the intensive care unit." Anesthesiology 136.3 (2022): 482-499.
  279. Schuurmans, Macé M., Christian Benden, and Ilhan Inci. "Practical approach to early postoperative management of lung transplant recipients." Swiss medical weekly 143.1516 (2013): w13773-w13773.
  280. Bierman, Morris I., et al. "Critical care management of lung transplant recipients." Journal of Intensive Care Medicine 6.3 (1991): 135-142.
  281. Della Rocca, Giorgio, Anita Brondani, and Maria Gabriella Costa. "Intraoperative hemodynamic monitoring during organ transplantation: what is new?." Current Opinion in Organ Transplantation 14.3 (2009): 291-296.
  282. Mendeloff, Eric N., et al. "Lung transplantation for pulmonary vascular disease." The Annals of thoracic surgery 73.1 (2002): 209-219.
  283. Zamora, Martin R. "Cytomegalovirus and lung transplantation." American Journal of Transplantation 4.8 (2004): 1219-1226.
  284. Patel, N., et al. "Is prevention the best treatment? CMV after lung transplantation." American Journal of Transplantation 12.3 (2012): 539-544.
  285. Danziger-Isakov, Lara A., et al. "The risk, prevention & outcome of cytomegalovirus after pediatric lung transplantation." Transplantation 87.10 (2009): 1541.
  286. Almaghrabi, Reem S., Ali S. Omrani, and Ziad A. Memish. "Cytomegalovirus infection in lung transplant recipients." Expert Review of Respiratory Medicine 11.5 (2017): 377-383.
  287. De Vlaminck, Iwijn, et al. "Noninvasive monitoring of infection and rejection after lung transplantation." Proceedings of the National Academy of Sciences 112.43 (2015): 13336-13341.
  288. Burguete, Sergio R., et al. "Lung transplant infection." Respirology 18.1 (2013): 22-38.
  289. Nosotti, Mario, Paolo Tarsia, and Letizia Corinna Morlacchi. "Infections after lung transplantation." Journal of thoracic disease 10.6 (2018): 3849.
  290. Alexander, B. D., and Victor F. Tapson. "Infectious complications of lung transplantation." Transplant Infectious Disease: Review article 3.3 (2001): 128-137
  291. Hopkins, Peter M., and Keith McNeil. "Evidence for immunosuppression in lung transplantation." Current Opinion in Organ Transplantation 13.5 (2008): 477-483.
  292. Spahr, J. E., et al. "Lung transplantation for cystic fibrosis: current concepts and one center"s experience." Journal of Cystic Fibrosis 6.5 (2007): 334-350.
  293. Scheffert, Jenna L., and Kashif Raza. "Immunosuppression in lung transplantation." Journal of thoracic disease 6.8 (2014): 1039.
  294. Monchaud, Caroline, and Pierre Marquet. "Pharmacokinetic optimization of immunosuppressive therapy in thoracic transplantation: part II." Clinical pharmacokinetics 48 (2009): 489-516.
  295. Lau C. L., Patterson G. A., Palmer S. M. Critical care aspects of lung transplantation //Journal of intensive care medicine. – 2004. – Т. 19. – №. 2. – С. 83-104.
  296. Potestio, Christopher, Desmond Jordan, and Bessie Kachulis. "Acute postoperative management after lung transplantation." Best Practice & Research Clinical Anaesthesiology 31.2 (2017): 273-284.
  297. McWilliams, Tanya J., et al. "Surveillance bronchoscopy in lung transplant recipients: risk versus benefit." The Journal of heart and lung transplantation 27.11 (2008): 1203-1209.
  298. Glanville, Allan R. "Bronchoscopic monitoring after lung transplantation." Seminars in respiratory and critical care medicine. Vol. 31. No. 02. © Thieme Medical Publishers, 2010.
  299. Kshettry, Vibhu R., et al. "Early and late airway complications after lung transplantation: incidence and management." The Annals of thoracic surgery 63.6 (1997): 1576-1583.
  300. Davidsen, Jesper Rømhild, et al. "Lung ultrasound in the assessment of pulmonary complications after lung transplantation." Ultraschall in der Medizin-European Journal of Ultrasound 41.02 (2020): 148-156.
  301. Droneau, Sylvain, et al. "Use of ultrasonography for lung transplant recipients on postoperative care." Journal of Ultrasound in Medicine 38.4 (2019): 1101-1108.
  302. Scuderi, Leonard J., et al. "Echocardiographic assessment of right and left ventricular function after single-lung transplantation." American Heart Journal 127.3 (1994): 636-642.
  303. Kato, Tomoko S., et al. "Left and right ventricular functional dynamics determined by echocardiograms before and after lung transplantation." The American journal of cardiology 116.4 (2015): 652-659.
  304. Glorion, Matthieu, et al. "Central versus peripheral cannulation of extracorporeal membrane oxygenation support during double lung transplant for pulmonary hypertension." European Journal of Cardio-Thoracic Surgery 54.2 (2018): 341-347.
  305. Lamb, Kathleen M., et al. "Arterial protocol including prophylactic distal perfusion catheter decreases limb ischemia complications in patients undergoing extracorporeal membrane oxygenation." Journal of vascular surgery 65.4 (2017): 1074-1079.
  306. Bidar, Frank, et al. "Venous or arterial thromboses after venoarterial extracorporeal membrane oxygenation support: frequency and risk factors." The Journal of Heart and Lung Transplantation 40.4 (2021): 307-315.
  307. Lunz, Dirk, et al. "Ischemia-related vascular complications of percutaneously initiated venoarterial extracorporeal membrane oxygenation: indication setting, risk factors, manifestation and outcome." Journal of Critical Care 52 (2019): 58-62.
  308. Fisser, Christoph, et al. "Arterial and venous vascular complications in patients requiring peripheral venoarterial extracorporeal membrane oxygenation." Frontiers in Medicine 9 (2022): 960716.
  309. Collins, Jannette, et al. "Frequency and CT findings of recurrent disease after lung transplantation." Radiology 219.2 (2001): 503-509.
  310. Krishnam, Mayil S., et al. "Postoperative complications of lung transplantation: radiologic findings along a time continuum." Radiographics 27.4 (2007): 957-974.
  311. Giraudo, Chiara, et al. "Imaging of pulmonary infections after lung transplantation: a pictorial essay of early and late computed tomography findings." Clinical and Translational Imaging 10.3 (2022): 311-319.
  312. Saeedan, Mnahi Bin, et al. "Imaging evaluation of airway complications after lung transplant." Journal of Computer Assisted Tomography 44.3 (2020): 314-327.
  313. Carlin B. W., Lega M., Veynovich B. Management of the patient undergoing lung transplantation: an intensive care perspective //Critical care nursing quarterly. – 2009. – Т. 32. – №. 1. – С. 49-57.
  314. Kim S. Y. et al. Critical Care after Lung Transplantation //Acute and critical care. – 2018. – Т. 33. – №. 4. – С. 206.
  315. Bonvillain R. W. et al. Post-operative infections in cystic fibrosis and non–cystic fibrosis patients after lung transplantation //The Journal of heart and lung transplantation. – 2007. – Т. 26. – №. 9. – С. 890-897.
  316. Coiffard, Benjamin, et al. "Worldwide clinical practices in perioperative antibiotic therapy for lung transplantation." BMC pulmonary medicine 20.1 (2020): 1-9.
  317. Clajus, Carolina, et al. "Therapeutic approach to respiratory infections in lung transplantation." Pulmonary Pharmacology & Therapeutics 32 (2015): 149-154.
  318. van den Bogaart, Lorena, and Oriol Manuel. "Antibiotic therapy for difficult-to-treat infections in lung transplant recipients: A practical approach." Antibiotics 11.5 (2022): 612.
  319. Corris P. A. et al. Targeted Antibiotic Prophylaxis for Lung Transplantation in Cystic Fibrosis Patients Colonised with Pseudomonas a eruginosa Using Multiple Combination Bactericidal Testing //Journal of Transplantation. – 2012.
  320. Aguilar‐Guisado M. et al. Pneumonia after lung transplantation in the RESITRA Cohort: a multicenter prospective study //American journal of transplantation. – 2007. – Т. 7. – №. 8. – С. 1989-1996.
  321. Quon B. S., Goss C. H., Ramsey B. W. Inhaled antibiotics for lower airway infections //Annals of the American Thoracic Society. – 2014. – Т. 11. – №. 3. – С. 425-434.
  322. Hayes Jr D. et al. Aerosolized vancomycin for the treatment of MRSA after lung transplantation //Respirology. – 2010. – Т. 15. – №. 1. – С. 184-186.
  323. Ludwig C. et al. Inhalation with Tobramycin® to improve healing of tracheobronchial reconstruction //European journal of cardio-thoracic surgery. – 2009. – Т. 35. – №. 5. – С. 797-800.
  324. Suhling H. et al. Inhaled colistin following lung transplantation in colonised cystic fibrosis patients //European Respiratory Journal. – 2013. – Т. 42. – №. 2. – С. 542-544.
  325. Moore C. A. et al. Effect of aerosolized antipseudomonals on P seudomonas positivity and bronchiolitis obliterans syndrome after lung transplantation //Transplant Infectious Disease. – 2017. – Т. 19. – №. 3. – С. e12688.
  326. Carillo C. et al. Colistin-based treatment of multidrug-resistant gram-negative bacterial pulmonary infections after lung transplantation //Transplantation proceedings. – Elsevier, 2019. – Т. 51. – №. 1. – С. 202-205.
  327. Patel T. S. et al. Antifungal prophylaxis in lung transplant recipients //Transplantation. – 2016. – Т. 100. – №. 9. – С. 1815-1826.
  328. Calvo V. et al. Antifungal prophylaxis during the early postoperative period of lung transplantation //Chest. – 1999. – Т. 115. – №. 5. – С. 1301-1304.
  329. Monforte V. et al. Nebulized amphotericin B concentration and distribution in the respiratory tract of lungtransplanted patients //Transplantation. – 2003. – Т. 75. – №. 9. – С. 1571-1574.
  330. Koo S. et al. A targeted peritransplant antifungal strategy for the prevention of invasive fungal disease after lung transplantation: a sequential cohort analysis //Transplantation. – 2012. – Т. 94. – №. 3. – С. 281-286.
  331. Kruger R. M. et al. The impact of ganciclovir-resistant cytomegalovirus infection after lung transplantation //Transplantation. – 1999. – Т. 68. – №. 9. – С. 1272-1279.
  332. Zamora M. R. et al. Following universal prophylaxis with intravenous ganciclovir and cytomegalovirus immune globulin, valganciclovir is safe and effective for prevention of CMV infection following lung transplantation //American Journal of Transplantation. – 2004. – Т. 4. – №. 10. – С. 1635-1642.
  333. Kroshus T. J. et al. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation //The Journal of thoracic and cardiovascular surgery. – 1997. – Т. 114. – №. 2. – С. 195-202.
  334. Ruttmann E. et al. Combined CMV prophylaxis improves outcome and reduces the risk for bronchiolitis obliterans syndrome (BOS) after lung transplantation //Transplantation. – 2006. – Т. 81. – №. 10. – С. 1415-1420.
  335. Chmiel C. et al. Ganciclovir/valganciclovir prophylaxis decreases cytomegalovirus-related events and bronchiolitis obliterans syndrome after lung transplantation //Clinical infectious diseases. – 2008. – Т. 46. – №. 6. – С. 831-839.
  336. Palmer S. M. et al. Extended valganciclovir prophylaxis to prevent cytomegalovirus after lung transplantation: a randomized, controlled trial //Annals of internal medicine. – 2010. – Т. 152. – №. 12. – С. 761-769.
  337. Geube M. A. et al. Increased intraoperative fluid administration is associated with severe primary graft dysfunction after lung transplantation //Anesthesia and analgesia. – 2016. – Т. 122. – №. 4. – С. 1081.
  338. Schultze B. S. Fluid Management in Lung Transplant Patients //Nursing Clinics. – 2017. – Т. 52. – №. 2. – С. 301-308.
  339. Baldwin M. R. et al. Hypoalbuminemia and early mortality after lung transplantation: a cohort study //American Journal of Transplantation. – 2012. – Т. 12. – №. 5. – С. 1256-1267.
  340. Koh, Wonshill, et al. "Postoperative management of children after lung transplantation." Seminars in Pediatric Surgery. Vol. 31. No. 3. WB Saunders, 2022.
  341. Barnes L. et al. Mechanical ventilation for the lung transplant recipient //Current pulmonology reports. – 2015. – Т. 4. – №. 2. – С. 88-96.
  342. Thakuria L. et al. Mechanical ventilation after lung transplantation //Journal of critical care. – 2016. – Т. 31. – №. 1. – С. 110-118.
  343. Lucangelo U. et al. Protective ventilation for lung transplantation //Current Opinion in Anesthesiology. – 2012. – Т. 25. – №. 2. – С. 170-174.
  344. Verbeek G. L., Myles P. S. Intraoperative protective ventilation strategies in lung transplantation //Transplantation Reviews. – 2013. – Т. 27. – №. 1. – С. 30-35.
  345. Verbeek G. L. et al. Intra‐operative protective mechanical ventilation in lung transplantation: a randomised, controlled trial //Anaesthesia. – 2017. – Т. 72. – №. 8. – С. 993-1004.
  346. Mitchell J. B. et al. Differential lung ventilation after single-lung transplantation for emphysema //Journal of cardiothoracic and vascular anesthesia. – 2002. – Т. 16. – №. 4. – С. 459-462.
  347. Kroshus T. J., Bolman III R. M., Kshettry V. R. Unilateral volume reduction after single-lung transplantation for emphysema //The Annals of thoracic surgery. – 1996. – Т. 62. – №. 2. – С. 363-368.
  348. Weill D. et al. Acute native lung hyperinflation is not associated with poor outcomes after single lung transplant for emphysema //The Journal of heart and lung transplantation. – 1999. – Т. 18. – №. 11. – С. 1080-1087.
  349. Yonan N. A. et al. Single lung transplantation for emphysema: predictors for native lung hyperinflation //The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation. – 1998. – Т. 17. – №. 2. – С. 192-201.
  350. Anderson M. B. et al. Volume reduction surgery in the native lung after single lung transplantation for emphysema //The Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation. – 1997. – Т. 16. – №. 7. – С. 752-757.
  351. Mullen J. C. et al. A randomized, controlled trial of daclizumab vs anti-thymocyte globulin induction for lung transplantation //The Journal of heart and lung transplantation. – 2007. – Т. 26. – №. 5. – С. 504-510.
  352. Burton C. M. et al. The incidence of acute cellular rejection after lung transplantation: a comparative study of anti-thymocyte globulin and daclizumab //The Journal of heart and lung transplantation. – 2006. – Т. 25. – №. 6. – С. 638-647.
  353. Hachem R. R. et al. The impact of induction on survival after lung transplantation: an analysis of the International Society for Heart and Lung Transplantation Registry //Clinical transplantation. – 2008. – Т. 22. – №. 5. – С. 603-608.
  354. Palmer S. M. et al. Rabbit antithymocyte globulin decreases acute rejection after lung transplantation: results of a randomized, prospective study //Chest. – 1999. – Т. 116. – №. 1. – С. 127-133.
  355. Mattei M. F. et al. Lower risk of infectious deaths in cardiac transplant patients receiving basiliximab versus anti-thymocyte globulin as induction therapy //The Journal of heart and lung transplantation. – 2007. – Т. 26. – №. 7. – С. 693-699.
  356. Clinckart F. et al. Basiliximab as an alternative to antithymocyte globulin for early immunosuppression in lung transplantation //Transplantation proceedings. – Elsevier, 2009. – Т. 41. – №. 2. – С. 607-609.
  357. Borro J. M. et al. Comparative study of basiliximab treatment in lung transplantation //Transplantation proceedings. – Elsevier, 2005. – Т. 37. – №. 9. – С. 3996-3998.
  358. Ailawadi G. et al. Effects of induction immunosuppression regimen on acute rejection, bronchiolitis obliterans, and survival after lung transplantation //The Journal of Thoracic and Cardiovascular Surgery. – 2008. – Т. 135. – №. 3. – С. 594-602.
  359. Bhorade S. M., Stern E. Immunosuppression for lung transplantation //Proceedings of the American Thoracic Society. – 2009. – Т. 6. – №. 1. – С. 47-53.
  360. Hachem R. R. et al. A comparison of basiliximab and anti-thymocyte globluin as induction agents after lung transplantation //The Journal of heart and lung transplantation. – 2005. – Т. 24. – №. 9. – С. 1320-1326.
  361. Ramirez C. B., Marino I. R. The role of basiliximab induction therapy in organ transplantation //Expert opinion on biological therapy. – 2007. – Т. 7. – №. 1. – С. 137-148.
  362. Brennan D. C., Schnitzler M. A. Long-term results of rabbit antithymocyte globulin and basiliximab induction //New England Journal of Medicine. – 2008. – Т. 359. – №. 16. – С. 1736-1738.
  363. Scheffert J. L., Raza K. Immunosuppression in lung transplantation //Journal of thoracic disease. – 2014. – Т. 6. – №. 8. – С. 1039.
  364. Brock M. V. et al. Induction therapy in lung transplantation: a prospective, controlled clinical trial comparing OKT3, anti-thymocyte globulin, and daclizumab //The Journal of heart and lung transplantation. – 2001. – Т. 20. – №. 12. – С. 1282-1290.
  365. Palmer, Scott M., et al. "Rabbit antithymocyte globulin decreases acute rejection after lung transplantation: results of a randomized, prospective study." Chest 116.1 (1999): 127-133.
  366. Hachem, Ramsey R., et al. "A comparison of basiliximab and anti-thymocyte globluin as induction agents after lung transplantation." The Journal of heart and lung transplantation 24.9 (2005): 1320-1326.
  367. Goldfarb, Samuel B., et al. "Induction therapy with antithymocyte globulin before reperfusion." The Annals of thoracic surgery 90.4 (2010): 1110-1115.
  368. Snell, G. I., et al. "A randomized, double‐blind, placebo‐controlled, multicenter study of rabbit ATG in the prophylaxis of acute rejection in lung transplantation." American Journal of Transplantation 14.5 (2014): 1191-1198.
  369. Clinckart, F., et al. "Basiliximab as an alternative to antithymocyte globulin for early immunosuppression in lung transplantation." Transplantation proceedings. Vol. 41. No. 2. Elsevier, 2009.
  370. Borro, J. M., et al. "Comparative study of basiliximab treatment in lung transplantation." Transplantation proceedings. Vol. 37. No. 9. Elsevier, 2005.
  371. de la Torre, M., et al. "Basiliximab in lung transplantation: preliminary experience." Transplantation proceedings. Vol. 37. No. 3. Elsevier, 2005.
  372. Morimura, Y., et al. "Use of Basiliximab in Recipients Who Required Dose Reduction or Discontinuation of Calcineurin Inhibitors Early After Lung Transplantation." The Journal of Heart and Lung Transplantation 41.4 (2022): S528.
  373. Zuckermann A. et al. Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: one-year results of a 2-center prospective randomized trial //The Journal of thoracic and cardiovascular surgery. – 2003. – Т. 125. – №. 4. – С. 891-900.
  374. Reichenspurner H. et al. Optimization of the immunosuppressive protocol after lung transplantation //Transplantation. – 1999. – Т. 68. – №. 1. – С. 67-71.
  375. Bittner H. B. et al. Preoperative introduction and maintenance immunosuppression therapy of oral-only tacrolimus, mycophenolate mofetil and steroids reduce acute rejection episodes after lung transplantation //European journal of cardio-thoracic surgery. – 2010. – Т. 38. – №. 3. – С. 268-276.
  376. Keenan, Robert J., et al. "Clinical trial of tacrolimus versus cyclosporine in lung transplantation." The Annals of thoracic surgery 60.3 (1995): 580-585.
  377. Small, Bronwyn, et al. "Induction and maintenance immunosuppression in lung transplantation." Indian Journal of Thoracic and Cardiovascular Surgery (2021): 1-18.
  378. Gerbase M. W. et al. Low doses of mycophenolate mofetil with low doses of tacrolimus prevent acute rejection and long-term function loss after lung transplantation //Transplantation proceedings. – Elsevier, 2001. – Т. 33. – №. 3. – С. 2146-2147.
  379. Treede, Hendrik, et al. "Tacrolimus versus cyclosporine after lung transplantation: a prospective, open, randomized two-center trial comparing two different immunosuppressive protocols //The Journal of heart and lung transplantation 20.5 (2001): 511-517.
  380. Bhorade S. M. et al. Comparison of three tacrolimus‐based immunosuppressive regimens in lung transplantation //American Journal of Transplantation. – 2003. – Т. 3. – №. 12. – С. 1570-1575.
  381. Reichenspurner H. Overview of tacrolimus-based immunosuppression after heart or lung transplantation //The Journal of heart and lung transplantation. – 2005. – Т. 24. – №. 2. – С. 119-130.
  382. Sarahrudi, Kambiz, et al. "International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection." The Journal of thoracic and cardiovascular surgery 127.4 (2004): 1126-1132.
  383. Knoop C., Haverich A., Fischer S. Immunosuppressive therapy after human lung transplantation //European Respiratory Journal. – 2004. – Т. 23. – №. 1. – С. 159-171.
  384. Hachem R. R. et al. A randomized controlled trial of tacrolimus versus cyclosporine after lung transplantation //The Journal of heart and lung transplantation. – 2007. – Т. 26. – №. 10. – С. 1012-1018.
  385. Keenan R. J. et al. Clinical trial of tacrolimus versus cyclosporine in lung transplantation //The Annals of thoracic surgery. – 1995. – Т. 60. – №. 3. – С. 580-585.
  386. Treede H. et al. Tacrolimus versus cyclosporine after lung transplantation: a prospective, open, randomized two-center trial comparing two different immunosuppressive protocols //The Journal of heart and lung transplantation. – 2001. – Т. 20. – №. 5. – С. 511-517.
  387. Parekh K., Trulock E., Patterson G. A. Use of cyclosporine in lung transplantation //Transplantation proceedings. – Elsevier, 2004. – Т. 36. – №. 2. – С. S318-S322.
  388. Artz M. A. et al. Conversion from cyclosporine to tacrolimus improves quality‐of‐life indices, renal graft function and cardiovascular risk profile //American Journal of Transplantation. – 2004. – Т. 4. – №. 6. – С. 937-945.
  389. Thorp M. et al. The effect of conversion from cyclosporine to tacrolimus on gingival hyperplasia, hirsutism and cholesterol //Transplantation. – 2000. – Т. 69. – №. 6. – С. 1218-1221.
  390. Emre S. et al. Treatment of tacrolimus‐related adverse effects by conversion to cyclosporine in liver transplant recipients //Transplant international. – 2000. – Т. 13. – №. 1. – С. 73-78.
  391. Borro J. M. et al. Conversion from cyclosporine to tacrolimus stabilizes the course of lung function in lung transplant recipients with bronchiolitis obliterans syndrome //Transplantation proceedings. – Elsevier, 2007. – Т. 39. – №. 7. – С. 2416-2419.
  392. Sarahrudi K. et al. The value of switching from cyclosporine to tacrolimus in the treatment of refractory acute rejection and obliterative bronchiolitis after lung transplantation //Transplant international. – 2002. – Т. 15. – №. 1. – С. 24-28.
  393. Treede H. et al. Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: results of a prospective, randomized international trial in lung transplantation //The Journal of heart and lung transplantation. – 2012. – Т. 31. – №. 8. – С. 797-804.
  394. Verleden G. M., Besse T., Maes B. Successfull conversion from cyclosporine to tacrolimus for gastric motor dysfunction in a lung transplant recipient //Transplantation. – 2002. – Т. 73. – №. 12. – С. 1974-1976.
  395. Cairn J. et al. Time-related changes in pulmonary function after conversion to tacrolimus in bronchiolitis obliterans syndrome //The Journal of heart and lung transplantation. – 2003. – Т. 22. – №. 1. – С. 50-57.
  396. Myers J. N. et al. Successful use of cyclosporine in a lung transplant recipient with tacrolimus-associated hemolytic uremic syndrome //The Journal of heart and lung transplantation. – 1999. – Т. 18. – №. 10. – С. 1024-1026.
  397. James J. A. et al. Reduction in gingival overgrowth associated with conversion from cyclosporin A to tacrolimus //Journal of clinical periodontology. – 2000. – Т. 27. – №. 2. – С. 144-148.
  398. Williams D., Haragsim L. Calcineurin nephrotoxicity //Advances in chronic kidney disease. – 2006. – Т. 13. – №. 1. – С. 47-55.
  399. Olyaei A. J., de Mattos A. M., Bennett W. M. Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies //Current opinion in critical care. – 2001. – Т. 7. – №. 6. – С. 384-389.
  400. Burdmann E. A. et al. Cyclosporine nephrotoxicity //Seminars in nephrology. – WB Saunders, 2003. – Т. 23. – №. 5. – С. 465-476.
  401. Sikma M. A. et al. High tacrolimus blood concentrations early after lung transplantation and the risk of kidney injury //European journal of clinical pharmacology. – 2017. – Т. 73. – №. 5. – С. 573-580.
  402. Wehbe E. et al. Recovery from AKI and short-and long-term outcomes after lung transplantation //Clinical Journal of the American Society of Nephrology. – 2013. – Т. 8. – №. 1. – С. 19-25.
  403. Bennett D. et al. Postoperative acute kidney injury in lung transplant recipients //Interactive cardiovascular and thoracic surgery. – 2019. – Т. 28. – №. 6. – С. 929-935.
  404. Sikma M. A. et al. Pharmacokinetics and toxicity of tacrolimus early after heart and lung transplantation //American Journal of Transplantation. – 2015. – Т. 15. – №. 9. – С. 2301-2313.
  405. Shitrit D. et al. Use of sirolimus and low-dose calcineurin inhibitor in lung transplant recipients with renal impairment: results of a controlled pilot study //Kidney international. – 2005. – Т. 67. – №. 4. – С. 1471-1475.
  406. Groetzner J. et al. Conversion to sirolimus and mycophenolate can attenuate the progression of bronchiolitis obliterans syndrome and improves renal function after lung transplantation //Transplantation. – 2006. – Т. 81. – №. 3. – С. 355-360.
  407. Parada M. T., Alba A., Sepúlveda C. Everolimus in lung transplantation in Chile //Transplantation proceedings. – Elsevier, 2010. – Т. 42. – №. 1. – С. 328-330.
  408. Stephany B. R. et al. Absence of proteinuria predicts improvement in renal function after conversion to sirolimus-based immunosuppressive regimens in lung transplant survivors with chronic kidney disease //The Journal of heart and lung transplantation. – 2009. – Т. 28. – №. 6. – С. 564-571.
  409. Roman A. et al. A retrospective 12-month study of conversion to everolimus in lung transplant recipients //Transplantation proceedings. – Elsevier, 2011. – Т. 43. – №. 7. – С. 2693-2698.
  410. Schneer S. et al. Renal function preservation with the mTOR inhibitor, Everolimus, after lung transplant //Clinical transplantation. – 2014. – Т. 28. – №. 6. – С. 662-668.
  411. Venuta F. et al. Recovery of chronic renal impairment with sirolimus after lung transplantation //The Annals of thoracic surgery. – 2004. – Т. 78. – №. 6. – С. 1940-1943.
  412. Landin L. et al. Improvement in renal function after late conversion to sirolimus-based immunosuppression in composite tissue allotransplantation //Transplantation. – 2010. – Т. 90. – №. 6. – С. 691-692.
  413. Gullestad L. et al. Long‐term outcomes of thoracic transplant recipients following conversion to everolimus with reduced calcineurin inhibitor in a multicenter, open‐label, randomized trial //Transplant International. – 2016. – Т. 29. – №. 7. – С. 819-829.
  414. Gottlieb J. et al. A randomized trial of everolimus‐based quadruple therapy vs standard triple therapy early after lung transplantation //American Journal of Transplantation. – 2019. – Т. 19. – №. 6. – С. 1759-1769.
  415. Palmer S. M. et al. Results of a randomized, prospective, multicenter trial of mycophenolate mofetil versus azathioprine in the prevention of acute lung allograft rejection //Transplantation. – 2001. – Т. 71. – №. 12. – С. 1772-1776.
  416. Whyte R. I. et al. Mycophenolate mofetil for obliterative bronchiolitis syndrome after lung transplantation //The Annals of thoracic surgery. – 1997. – Т. 64. – №. 4. – С. 945-948.
  417. Ross D. J. et al. Mycophenolate mofetil versus azathioprine immunosuppressive regimens after lung transplantation: preliminary experience //The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation. – 1998. – Т. 17. – №. 8. – С. 768-774.
  418. Zuckermann A. et al. Comparison between mycophenolate mofetil-and azathioprine-based immunosuppressions in clinical lung transplantation //The Journal of heart and lung transplantation. – 1999. – Т. 18. – №. 5. – С. 432-440.
  419. Celik M. R. et al. Tacrolimus and azathioprine versus cyclosporine and mycophenolate mofetil after lung transplantation: a retrospective cohort study //The Journal of heart and lung transplantation. – 2009. – Т. 28. – №. 7. – С. 697-703.
  420. Cummins D. et al. Myelosuppression associated with azathioprine-allopurinol interaction after heart and lung transplantation //Transplantation. – 1996. – Т. 61. – №. 11. – С. 1661-1662.
  421. Snell G. I. et al. Everolimus versus azathioprine in maintenance lung transplant recipients: an international, randomized, double‐blind clinical trial //American journal of transplantation. – 2006. – Т. 6. – №. 1. – С. 169-177.
  422. Ruttens D. et al. Prophylactic azithromycin therapy after lung transplantation: post hoc analysis of a randomized controlled trial //American Journal of Transplantation. – 2016. – Т. 16. – №. 1. – С. 254-261.
  423. Corris P. A. et al. A randomised controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome (BOS) post lung transplantation //Thorax. – 2015. – Т. 70. – №. 5. – С. 442-450.
  424. Vos R. et al. A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation //European Respiratory Journal. – 2011. – Т. 37. – №. 1. – С. 164-172.
  425. Kingah P. L., Muma G., Soubani A. Azithromycin improves lung function in patients with post‐lung transplant bronchiolitis obliterans syndrome: a meta‐analysis //Clinical Transplantation. – 2014. – Т. 28. – №. 8. – С. 906-910.
  426. Olivari M. T. et al. Triple-drug immunosuppression with steroid discontinuation by six months after heart transplantation //Journal of Heart and Lung Transplantation. – 1995. – Т. 14. – №. 1 I. – С. 127-135.
  427. Taylor D. O. et al. Improved long-term survival after heart transplantation predicted by successful early withdrawal from maintenance corticosteroid therapy //The Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation. – 1996. – Т. 15. – №. 10. – С. 1039-1046.
  428. Borro J. M. et al. Steroid withdrawal in lung transplant recipients //Transplantation proceedings. – Elsevier, 2005. – Т. 37. – №. 9. – С. 3991-3993.
  429. Shitrit D. et al. Successful steroid withdrawal in lung transplant recipients: result of a pilot study //Respiratory medicine. – 2005. – Т. 99. – №. 5. – С. 596-601.
  430. De Pablo A. et al. Recommendations on the use of everolimus in lung transplantation //Transplantation Reviews. – 2013. – Т. 27. – №. 1. – С. 9-16.
  431. Azzola A. et al. Everolimus and mycophenolate mofetil are potent inhibitors of fibroblast proliferation after lung transplantation1 //Transplantation. – 2004. – Т. 77. – №. 2. – С. 275-280.
  432. McShane P. J., Garrity Jr E. R. Minimization of immunosuppression after lung transplantation: current trends //Transplant International. – 2009. – Т. 22. – №. 1. – С. 90-95.
  433. Strueber M. et al. Everolimus versus mycophenolate mofetil de novo after lung transplantation: a prospective, randomized, open‐label trial //American Journal of Transplantation. – 2016. – Т. 16. – №. 11. – С. 3171-3180.
  434. Parada M. T. et al. Long-term use of everolimus in lung transplant patients //Transplantation proceedings. – Elsevier, 2011. – Т. 43. – №. 6. – С. 2313-2315.
  435. Ivulich S. et al. The Successful Evolution of Everolimus Based Immunosuppression (IS) in a Large Lung Transplant (LTx) Cohort: 14 Years Experience //The Journal of Heart and Lung Transplantation. – 2020. – Т. 39. – №. 4. – С. S322.
  436. Salman J. et al. Role for primary immunosuppression with everolimus after pulmonary transplantation //Transplant immunology. – 2018. – Т. 49. – С. 12-19.
  437. Morimura, Y., et al. "Use of Basiliximab in Recipients Who Required Dose Reduction or Discontinuation of Calcineurin Inhibitors Early After Lung Transplantation." The Journal of Heart and Lung Transplantation 41.4 (2022): S528.
  438. Kim, Ha Eun, et al. "Preoperative corticosteroid use and early postoperative bronchial anastomotic complications after lung transplantation." The Korean Journal of Thoracic and Cardiovascular Surgery 51.6 (2018): 384.
  439. Mallory, G. B., and T. L. Spray. "Paediatric lung transplantation." European Respiratory Journal 24.5 (2004): 839-845.
  440. Crowther, Barrett. "Immunosuppression in pediatric SOT." Clin J Am Soc Nephrol 11 (2016): 332-43.
  441. Burcham P. et al. Immunosuppression drug therapy in lung transplantation for cystic fibrosis //Pediatric Drugs. – 2017. – Т. 19. – №. 4. – С. 339-346.
  442. Monchaud, Caroline, and Pierre Marquet. "Pharmacokinetic optimization of immunosuppressive therapy in thoracic transplantation: part I." Clinical pharmacokinetics 48.7 (2009): 419-462.
  443. Penninga L. et al. Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients //Cochrane Database of Systematic Reviews. – 2013. – №. 5.
  444. Treede H. et al. Tacrolimus versus cyclosporine after lung transplantation: a prospective, open, randomized two-center trial comparing two different immunosuppressive protocols //The Journal of heart and lung transplantation. – 2001. – Т. 20. – №. 5. – С. 511-517.
  445. Thompson, Melissa L., Jeremy D. Flynn, and Timothy M. Clifford. "Pharmacotherapy of lung transplantation: an overview." Journal of Pharmacy Practice 26.1 (2013): 5-13.
  446. Caruba T. et al. Substitution of corticosteroid with everolimus after lung transplantation: a pediatric case report //Pharmacy world & science. – 2010. – Т. 32. – №. 3. – С. 347-349.
  447. Kovarik, John M., et al. "Everolimus in pulmonary transplantation: pharmacokinetics and exposure–response relationships." The Journal of heart and lung transplantation 25.4 (2006): 440-446.
  448. Li D. et al. Azithromycin prophylaxis after lung transplantation is associated with improved overall survival //The Journal of Heart and Lung Transplantation. – 2020. – Т. 39. – №. 12. – С. 1426-1434.
  449. Sciurba F. C. et al. Evidence of an altered pattern of breathing during exercise in recipients of heart–lung transplants //New England Journal of Medicine. – 1988. – Т. 319. – №. 18. – С. 1186-1192.
  450. Jing G. Q. et al. Pulmonary rehabilitation after lung transplantation with severe complications: A case report //Canadian journal of respiratory therapy: CJRT= Revue canadienne de la therapie respiratoire: RCTR. – 2017. – Т. 53. – №. 3. – С. 45.
  451. Munro P. E. et al. Pulmonary rehabilitation following lung transplantation //Transplantation proceedings. – Elsevier, 2009. – Т. 41. – №. 1. – С. 292-295.
  452. Theodore J. et al. Cardiopulmonary function at maximum tolerable constant work rate exercise following human heart-lung transplantation //Chest. – 1987. – Т. 92. – №. 3. – С. 433-439.
  453. Banner N. R. et al. Cardiopulmonary response to dynamic exercise after heart and combined heart-lung transplantation //Heart. – 1989. – Т. 61. – №. 3. – С. 215-223.
  454. Maury G. et al. Skeletal muscle force and functional exercise tolerance before and after lung transplantation: a cohort study //American Journal of Transplantation. – 2008. – Т. 8. – №. 6. – С. 1275-1281.
  455. Langer D. et al. Exercise training after lung transplantation improves participation in daily activity: a randomized controlled trial //American Journal of Transplantation. – 2012. – Т. 12. – №. 6. – С. 1584-1592.
  456. Stiebellehner L. et al. Aerobic endurance training program improves exercise performance in lung transplant recipients //Chest. – 1998. – Т. 113. – №. 4. – С. 906-912.
  457. Dierich M. et al. The influence of clinical course after lung transplantation on rehabilitation success //Transplant International. – 2013. – Т. 26. – №. 3. – С. 322-330.
  458. Mathur S., Hornblower E., Levy R. D. Exercise training before and after lung transplantation //The Physician and sportsmedicine. – 2009. – Т. 37. – №. 3. – С. 78-87.
  459. Walsh J. R. et al. Impaired exercise capacity after lung transplantation is related to delayed recovery of muscle strength //Clinical Transplantation. – 2013. – Т. 27. – №. 4. – С. E504-E511.
  460. Wang X. N. et al. Skeletal muscle oxidative capacity, fiber type, and metabolites after lung transplantation //American journal of respiratory and critical care medicine. – 1999. – Т. 160. – №. 1. – С. 57-63.
  461. Song J. H. et al. Feasibility of immediate in-Intensive Care Unit pulmonary rehabilitation after lung transplantation: A single center experience //Acute and Critical Care. – 2018. – Т. 33. – №. 3. – С. 146.
  462. Choi E. J. et al. Intensive pulmonary rehabilitation in a pediatric lung transplantation patient: A case report //Medicine. – 2021. – Т. 100. – №. 17.
  463. Müller, Christian, et al. "Lung procurement by low-potassium dextran and the effect on preservation injury." Transplantation 68.8 (1999): 1139-1143.
  464. Fischer, Stefan, et al. "Low-potassium dextran preservation solution improves lung function after human lung transplantation." The Journal of thoracic and cardiovascular surgery 121.3 (2001): 594-596.
  465. Oto, Takahiro, et al. "Early outcomes comparing Perfadex, Euro-Collins, and Papworth solutions in lung transplantation." The Annals of thoracic surgery 82.5 (2006): 1842-1848.
  466. Gámez, P., et al. "Improvements in lung preservation: 3 years" experience with a low-potassium dextran solution." Archivos de Bronconeumología ((English Edition)) 41.1 (2005): 16-19.
  467. Arnaoutakis, George J., et al. "Low potassium dextran is superior to University of Wisconsin solution in high-risk lung transplant recipients." The Journal of heart and lung transplantation 29.12 (2010): 1380-1387.
  468. Aoe, Motoi, et al. "Administration of prostaglandin E1 after lung transplantation improves early graft function." The Annals of thoracic surgery 58.3 (1994): 655-661.
  469. Higgins, Robert SD, et al. "Improved ultrastructural lung preservation with prostaglandin E1 as donor pretreatment in a primate model of heart-lung transplantation." The Journal of Thoracic and Cardiovascular Surgery 105.6 (1993): 965-971
  470. de Perrot, Marc, et al. "PROSTAGLANDIN E1 PROTECTS LUNG TRANSPLANTS FROM ISCHEMIA-REPERFUSION INJURY: A SHIFT FROM PRO-TO ANTI-INFLAMMATORY CYTOKINES1." Transplantation 72.9 (2001): 1505-1512.
  471. DeCampos, K. N., et al. "Prevention of rapid reperfusion-induced lung injury with prostaglandin E1 during the initial period of reperfusion." The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation 17.11 (1998): 1121-1128.
  472. Edelman, J. James B., et al. "Custodiol for myocardial protection and preservation: a systematic review." Annals of cardiothoracic surgery 2.6 (2013): 717.
  473. Cypel, Marcelo, et al. "Normothermic ex vivo lung perfusion in clinical lung transplantation." New England journal of medicine 364.15 (2011): 1431-1440.
  474. Ingemansson, Richard, et al. "Clinical transplantation of initially rejected donor lungs after reconditioning ex vivo." The Annals of thoracic surgery 87.1 (2009): 255-260.
  475. Zych, Bartlomiej, et al. "Early outcomes of bilateral sequential single lung transplantation after ex-vivo lung evaluation and reconditioning." The Journal of heart and lung transplantation 31.3 (2012): 274-281.
  476. Machuca, Tiago N., Marcelo Cypel. "Ex vivo lung perfusion." Journal of thoracic disease 6.8 (2014): 1054.
  477. Machuca, Tiago N., Marcelo Cypel, and Shaf Keshavjee. "Advances in lung preservation." Surgical Clinics 93.6 (2013): 1373-1394.
  478. Danziger-Isakov, Lara A., et al. "The risk, prevention, and outcome of cytomegalovirus after pediatric lung transplantation." Transplantation 87.10 (2009): 1541-1548.
  479. Danziger‐Isakov, Lara A., et al. "Variability in standard care for cytomegalovirus prevention and detection in pediatric lung transplantation: Survey of eight pediatric lung transplant programs." Pediatric transplantation 7.6 (2003): 469-473.
  480. Zuk, Dalyce M., et al. "An international survey of cytomegalovirus management practices in lung transplantation." Transplantation 90.6 (2010): 672-676.
  481. Wawrzyńska L, Kurzyna M, Kuca P, Fijałkowska A, Kober J, Florczyk M, Torbicki A. Autoimmunologiczne choroby tarczycy u chorych na pierwotne nadciśnienie płucne [Autoimmune thyroid diseases in patients with primary pulmonary hypertension]. Pneumonol Alergol Pol. 2004;72(1-2):19-22.
  482. Matsyura O, Besh L, Borysiuk O, Besh O, Kondratyuk M, Sorokopud O, Zubchenko S. Efficacy of primary rehabilitation measures associated with the development of recurrent bronchial obstruction syndrome in young children with respiratory disorders in neonatal period. Wiad Lek. 2023;76(1):17-25. doi: 10.36740/WLek202301102.
  483. Sweet SC. Pediatric Lung Transplantation. Respir Care. 2017 Jun;62(6):776-798. doi: 10.4187/respcare.05304.
  484. Jaleel A, Chilumula M, Chukkala Satya SG, Singnale P, Telikicherla UR, Pandurangi R. The Assessment of Nutritional Status of Adolescents Aged 15-18 Years Using BMI Cutoffs and BMI Z Scores: A Secondary Analysis of National Family Health Survey-5 (2019-21) Data. Cureus. 2024 May 7;16(5):e59800. doi: 10.7759/cureus.59800.
  485. Ranganathan K, Worley S, Michaels MG, Arrigan S, Aurora P, Ballmann M, Boyer D, Conrad C, Eichler I, Elidemir O, Goldfarb S, Mallory GB Jr, Mogayzel PJ, Parakininkas D, Solomon M, Visner G, Sweet SC, Faro A, Danziger-Isakov L. Cytomegalovirus immunoglobulin decreases the risk of cytomegalovirus infection but not disease after pediatric lung transplantation. J Heart Lung Transplant. 2009 Oct;28(10):1050-6. doi: 10.1016/j.healun.2009.04.032.
  486. Armitage JM, Kurland G, Michaels M, Cipriani LA, Griffith BP, Fricker FJ. Critical issues in pediatric lung transplantation. J Thorac Cardiovasc Surg. 1995 Jan;109(1):60-4; discussion 64-5. doi: 10.1016/S0022-5223(95)70420-5.
  487. Wanderer JP, Ehrenfeld JM, Epstein RH, Kor DJ, Bartz RR, Fernandez-Bustamante A, Vidal Melo MF, Blum JM. Temporal trends and current practice patterns for intraoperative ventilation at U.S. academic medical centers: a retrospective study. BMC Anesthesiol. 2015 Mar 28;15:40. doi: 10.1186/s12871-015-0010-3.
  488. Spinelli E, Pesenti A, Slobod D, Fornari C, Fumagalli R, Grasselli G, Volta CA, Foti G, Navalesi P, Knafelj R, Pelosi P, Mancebo J, Brochard L, Mauri T. Clinical risk factors for increased respiratory drive in intubated hypoxemic patients. Crit Care. 2023 Apr 11;27(1):138. doi: 10.1186/s13054-023-04402-z.
  489. Burcham P, Sarzynski L, Khalfoun S, Novak KJ, Miller JC, Tumin D, Hayes D Jr. Immunosuppression Drug Therapy in Lung Transplantation for Cystic Fibrosis. Paediatr Drugs. 2017 Aug;19(4):339-346. doi: 10.1007/s40272-017-0236-2. Erratum in: Paediatr Drugs. 2018 Apr;20(2):207. doi: 10.1007/s40272-018-0285-1.
  490. Sohn YM, Ko RE, Park HJ, Choo E, Jung M, Lee S, Jeon K. Clinical pharmacokinetic study of tacrolimus in continuous intravenous administration for lung transplantation. J Thorac Dis. 2023 Jun 30;15(6):3431-3436. doi: 10.21037/jtd-22-1760.
  491. Orens JB, Estenne M, Arcasoy S, et al.: International guidelines for the selection of lung transplant candidates: 2006 update—a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2006;25:745–55.
  492. Weill D, Benden C, Corris PA, et al.: A consensus document for the selection of lung transplant candidates: 2014—an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2015.
  493. Chambers DC, Cherikh WS, Goldfarb SB, et al.: The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-fifth adult lung and heart-lung transplant report-2018; Focus theme: Multiorgan Transplantation. J Heart Lung Transplant 2018;37:1169–83.
  494. Weill D. Lung transplantation: indications and contraindications. J Thorac Dis. 2018 Jul;10(7):4574-4587. doi: 10.21037/jtd.2018.06.141.
  495. Wang, T.K.M. et al. Bone Density Before and After Heart or Lung Transplantation—A Longitudinal Study Heart, Lung and Circulation, Volume 21, Issue 8, 519
  496. Hartmuth B. Bittner, Markus J. Barten, Christian Binner, Sven Lehmann, Jens Garbade, Stefan Hammerschmidt, Hubert Wirtz, Friedrich W. Mohr, Preoperative introduction and maintenance immunosuppression therapy of oral-only tacrolimus, mycophenolate mofetil and steroids reduce acute rejection episodes after lung transplantation, European Journal of Cardio-Thoracic Surgery, Volume 38, Issue 3, September 2010, Pages 268–276, https://doi.org/10.1016/j.ejcts.2010.01.066
  497. Knoop C, Haverich A, Fischer S. Immunosuppressive therapy after human lung transplantation. Eur Respir J. 2004 Jan;23(1):159-71. doi: 10.1183/09031936.03.00039203.
  498. Lama R, Santos F, Algar FJ, Alvarez A, Baamonde C. Lung transplants with tacrolimus and mycophenolate mofetil: a review. Transplant Proc. 2003 Aug;35(5):1968-73. doi: 10.1016/s0041-1345(03)00569-4.
  499. Ross D.J.,Waters P.F., Levine M., Kramer M., Ruzevich S., Kass R.M. Mycophenolate mofetil versus azathioprine immunosuppressive regimens after lung transplantation: Preliminary experience(Article) / Journal of Heart and Lung Transplantation/ Volume 17, Issue 8, 1998, P. 768-774.
  500. Palmer S.M., Baz M.A. , Sanders L. et al. Results of a randomized, prospective, multicenter trial of mycophenolate mofetil versus azathioprine in the prevention of acute lung allograft rejection(Article) Transplantation, 71 (2001), p. 1772-1776.
  501. Small B, Au J, Brink H, Shah I, Strah H. Induction and maintenance immunosuppression in lung transplantation. Indian J Thorac Cardiovasc Surg. 2022 Jul;38(Suppl 2):300-317. doi: 10.1007/s12055-021-01225-x. Epub 2021 Sep 17.
  502. Sharma D, Krishnan GS, Sharma N, Chandrashekhar A. Current perspective of immunomodulators for lung transplant. Indian J Thorac Cardiovasc Surg. 2022 Sep;38(5):497-505. doi: 10.1007/s12055-022-01388-1. Epub 2022 Jul 14.
  503. Suzuki H, Matsuda Y, Noda M, Oishi H, Watanabe T, Sado T, Yamada M, Tamada T, Okada Y. Management of De Novo Mycobacterial Infection After Lung Transplantation Without Rifampicin: Case Series of a Single Institution. Transplant Proc. 2018 Nov;50(9):2764-2767. doi: 10.1016/j.transproceed.2018.03.058. Epub 2018 Mar 15.

Для продолжения работы требуется Регистрация
На предыдущую страницу

Предыдущая страница

Следующая страница

На следующую страницу
Список литературы
На предыдущую главу Предыдущая глава
оглавление
Следующая глава На следующую главу

Оглавление

Данный блок поддерживает скрол*